UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | Y
Number of items: 505.

A

Ablashi, D; Chatlynne, L; Cooper, H; Thomas, D; Yadav, M; Norhanom, AW; Chandana, AK; (1999) Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. BRIT J CANCER , 81 (5) 893 - 897.

Aiello, A; Du, MQ; Peng, HZ; Pezzella, F; Papini, D; Giardini, R; Pilotti, S; (1999) Simultaneous phenotypically distinct but clonally identical mucosa-associated lymphoid tissue and follicular lymphoma in a patient with Sjogren's syndrome. Blood , 94 (7) pp. 2247-2251.

Aiello, A; Giardini, R; Tondini, C; Balzarotti, M; Diss, T; Peng, H; Delia, D; (1999) PCR-based clonality analysis: a reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALT lymphomas? Histopathology , 34 (4) pp. 326-330.

Al-Azraqi, A; Angus, B; Gokul, S; Sinha, D; Calvert, AH; Lunec, J; (1999) Bcl-2 expression is a potential prognostic co-factor with P53-mutation status in epithelial ovarian carcinoma. British Journal of Cancer , 80 178-.

Al-Azraqi, A; Angus, B; Gokul, S; Sinha, D; Calvert, AH; Lunec, J; (1999) Bcl-2 expression is a potential prognostic co-factor with P53-mutation status in epithelial ovarian carcinoma. BRIT J CANCER , 80 73 - 73.

Al-Mufti, RAM; Pedley, RB; Marshall, D; Begent, RHJ; Hilson, A; Winslet, MC; Hobbs, KEF; (1999) In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines. BRIT J CANCER , 79 (11-12) 1665 - 1671.

Al-Mufti, RAM; Pedley, RB; Marshall, D; Begent, RHJ; Winslet, MCAH; K, EF; (1999) In vitro assessment of lipiodol targeted radiotherapy for primary and metastatic liver cancers. British Journal of Cancer , 79 pp. 1665-1671.

Allford, SL; Harrison, P; Cohen, H; Mackie, IJ; Machin, SJ; (1999) Platelet activation in thrombotic thrombocytopenic purpura. In: THROMB HAEMOSTASIS. (pp. 361 - 361). F K SCHATTAUER VERLAG GMBH

Allford, SL; Harrison, P; Mackie, IJ; Cohen, H; Machin, SJ; (1999) Platelet activation markers in thrombotic thrombocytopenic purpura. Presented at: UNSPECIFIED.

Anthony, A; Dhillon, AP; Pounder, RE; Wakefield, AJ; (1999) The colon mesenteric margin is most susceptible to injury in an experimental model of colonic ulceration. ALIMENT PHARM THER , 13 (4) 531 - 535.

Anthony, A; Sim, R; Dhillon, AP; Guillaume, JL; Strosberg, AD; Pounder, RE; Wakefield, AJ; (1999) Beta(3)-adrenoceptors co-localise with somatostatin-positive D-cells in human pancreatic islets and duodenal neuroendocrine cells. GUT , 44 A48 - A48.

Anthony, A; Sim, R; Dhillon, AP; Pounder, RE; Wakefield, AJ; (1999) Granulomatous vasculitis in Crohn's disease: An association with the extramural mesenteric vasculature. GUT , 44 A43 - A43.

Aramburu-González, JA; Rodríguez-Justo, M; Jiménez-Reyes, J; Santonja, C; (1999) A case of soft tissue mesenchymal chondrosarcoma metastatic to skin, clinically mimicking keratoacanthoma. Am J Dermatopathol , 21 (4) pp. 392-394.

Ardeshna, KM; Addison, IE; Pizzey, AR; Linch, DC; Devereux, S; Khwaja, A; (1999) P38 stress-activated protein kinase activity is required for the lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. BRIT J HAEMATOL , 105 33 - 33.

Ardeshna, KM; Linch, DC; Devereux, S; Khwaja, A; (1999) p38 stress-activated protein kinase and NF-kappa B activity are required for lipopolysaccharide-induced maturation of monocyte-derived dendritic cells. BLOOD , 94 (10) 214A - 214A.

Ardeshna, KM; Pizzey, AR; Thomas, NSB; Linch, DC; Devereux, S; (1999) Proliferative capacity and susceptibility to retroviral transduction of CD34 and monocyte derived dendritic cells. BRIT J HAEMATOL , 105 29 - 29.

Arnold, J; Holmes, Z; Pickering, W; Regan, L; Cohen, H; (1999) Prevalence of anti-beta 2 glycoprotein 1 IgG antibodies in women with recurrent miscarriage. In: THROMB HAEMOSTASIS. (pp. 535 - 536). F K SCHATTAUER VERLAG GMBH

Arnold, J; Holmes, Z; Pickering, W; Regan, L; Cohen, H; (1999) Prevalence of anti-beta 2 glycoprotein 1 IgG antibodies in women with recurrent miscarriage. In: BRIT J HAEMATOL. (pp. 45 - 45). BLACKWELL SCIENCE LTD

Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Dewsbury, PJ; Endicott, JA; Gibson, AE; (1999) In vitro growth activity of novel purine- and pyrimidine-based CDK1 and CDK2 inhibitors. British Journal of Cancer , 80 110-.

B

Backos, M; Rai, R; Baxter, N; Chilcott, IT; Cohen, H; Regan, L; (1999) Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol , 106 (2) pp. 102-107.

Bagdi, E; Diss, TC; Munson, P; Isaacson, PG; (1999) Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood , 94 (1) pp. 260-264.

Bagshawe, KD; Sharma, SK; Burke, PJ; Melton, RG; Knox, RJ; (1999) Developments with targeted enzymes in cancer therapy. CURRENT OPINION IN IMMUNOLOGY , 11 (5) pp. 579-583. 10.1016/S0952-7915(99)00004-7.

Banks, PM; Isaacson, PG; (1999) MALT lymphoma in 1997. Where do we stand? American Journal of Clinical Pathology , 111 (1 supp) S75-S83.

Barnouin, K; Fredersdorf, S; Eddaoudi, A; Mittnacht, S; Pan, LX; Du, MQ; Lu, X; (1999) Antiproliferative function of p27(kip1) is frequently inhibited in highly malignant Burkitt's lymphoma cells. ONCOGENE , 18 (46) 6388 - 6397.

Barnouin, K; Fredersdorf, S; Eddaoudi, A; Mittnacht, S; Pan, LX; Du, MQ; Lu, X; (1999) Antiproliferative function of p27(kip1) is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene , 18 (46) pp. 6388-6397.

Bateman, A; Murphy, S; Emiliusen, L; Ruchatz, A; Melcher, A; Fielding, A; Cattaneo, R; (1999) Fusogenic membrane glycoproteins - A novel class of cytotoxic genes with immunostimulatory properties. GENE THERAPY , 6 S6-S6.

Bates, AW; (1999) Ethics of human reproductive cloning. J ROY SOC MED , 92 (3) 157 - 158.

Bates, AW; Dodd, SM; (1999) Anomalies in cephalothoracopagus synotus twins and their implications for morphogenesis in conjoined twins. PEDIATR DEVEL PATHOL , 2 (5) 464 - 472.

Bates, AW; Feakins, RM; Scheimberg, I; (1999) Congenital gastro-intestinal stromal tumour: a comparison with similar tumours in adult subjects. J PATHOL , 187 19A - 19A.

Bates, AW; Norton, A; Baithun, SI; (1999) Clinical and pathological features of primary and secondary lymphomas of the urinary bladder. J PATHOL , 187 35A - 35A.

Batey, MA; Wright, JG; Simmonds, D; Proctor, M; Chapman, F; Fishwick, K; Azzabi, A; (1999) Population pharmacokinetics of CMF in the adjuvant treatment of breast cancer. British Journal of Cancer , 80 259-.

Batey, MA; Wright, JG; Simmonds, D; Proctor, M; Chapman, F; Fishwick, K; Azzabi, A; (1999) Population pharmacokinetics of CMF in the adjuvant treatment of breast cancer. BRIT J CANCER , 80 93 - 93.

Bay, JO; Uhrhammer, N; Pernin, D; Presneau, N; Tchirkov, A; Vuillaume, M; Laplace, V; (1999) High incidence of cancer in a family segregating a mutation of the ATM gene: Possible role of ATM heterozygosity in cancer. HUM MUTAT , 14 (6) 485 - 492.

Beck, S; Geraghty, D; Inoko, H; Rowen, L; Aguado, B; Bahram, S; Campbell, RD; (1999) Complete sequence and gene map of a human major histocompatibility complex. NATURE , 401 (6756) 921 - 923.

Beck, S; Olek, A; Walter, J; (1999) From genomics to epigenomics: a loftier view of life. NAT BIOTECHNOL , 17 (12) 1144 - 1144.

Beck, S; Trowsdale, J; (1999) Sequence organisation of the class II region of the human MHC. IMMUNOL REV , 167 201 - 210.

Begent, RHJ; (1999) Targeting cancer therapy. In: BRITISH JOURNAL OF CANCER. (pp. 104 - 109). CHURCHILL LIVINGSTONE

Bentzen, SM; Saunders, MI; Dische, S; (1999) Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiotherapy and Oncology , 53 pp. 219-226.

Berkenstadt, H; Rosenthal, T; Segal, E; Peleg, E; Ben-Ari, G; Perel, A; Hackshaw, A; (1999) Elevated plasma atrial natriuretic peptide levels after occlusion of the thoracic aorta. Chest , 115 (1) pp. 130-134.

Bilanges, B; Varrault, A; Basyuk, E; Rodriguez, C; Mazumdar, A; Pantaloni, C; Bockaert, J; (1999) Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene , 18 (27) pp. 3979-3988. 10.1038/sj.onc.1202933.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; (1999) Nomenclature for Factors of the HLA System, 1998. HUMAN IMMUNOLOGY , 60 (4) pp. 361-395.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; (1999) Nomenclature for factors of the HLA system, 1998. European Journal of Immunogenetics , 26 pp. 81-116.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; (1999) Nomenclature for factors of the HLA system, 1998. Vox Sanguinis , 77 pp. 164-191.

Bodmer, JG; Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; (1999) Nomenclature for factors of the HLA system, 1998. Tissue Antigens , 53 pp. 407-446.

Borthwick, NJ; Wickremasinghe, RG; Lewin, J; Fairbanks, L; Bofill, M; (1999) Activation associated necrosis in HIV infection. The Journal of Infectious Diseases , 179 pp. 352-360.

Borthwick, NJ; Wickremasinghe, RG; Lewin, J; Fairbanks, LD; Bofill, M; (1999) Activation-associated necrosis in human immunodeficiency virus infection. J INFECT DIS , 179 (2) 352 - 360.

Boshoff, C; (1999) Human herpesvirus-8 encoded chemokines. In: EUROPEAN CYTOKINE NETWORK. (pp. 292 - 295). JOHN LIBBEY EUROTEXT LTD

Boshoff, C; (1999) Kaposi's sarcoma associated herpesvirus. CANCER SURV , 33 157 - 190.

Boshoff, C; Weiss, RA; (1999) HHV8/KSHV - Introduction. SEMIN CANCER BIOL , 9 (3) 149 - 150.

Boshoff, C; Weiss, RA; (1999) Introduction. Semin Cancer Biol , 9 (3) pp. 149-150. 10.1006/scbi.1999.0120.

Bourboulia, D; Boshoff, C; Sitas, F; (1999) HHV-8 peripheral-blood viral load and the titer of antibodies against HHV-8 - Reply. NEW ENGL J MED , 341 (16) 1242 - 1242.

Boxer, G; Stuart-Smith, S; Flynn, A; Green, A; Begent, R; (1999) Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome. BRITISH JOURNAL OF CANCER , 80 (5-6) pp. 922-926. 10.1038/sj.bjc.6690443.

Bramwell, VHC; Steward, WP; Nooij, M; Whelan, J; Craft, AW; Grimer, RJ; Taminau, AHM; (1999) Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European osteosarcoma intergroup study. J CLIN ONCOL , 17 (10) 3260 - 3269.

Bramwell, VHC; Steward, WP; Nooij, M; Whelan, J; Craft, AW; Grimer, RJ; Taminau, AHM; (1999) Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European osteosarcoma intergroup study. Journal Of Clinical Oncology , 17 pp. 3260-3269.

Brett, BT; Khan, K; Savage, K; Michaeli, D; Grimes, S; Dhillon, AP; Pounder, RE; (1999) The effect of antibodies raised against gastrimmune on the proliferation of human pancreatic carcinoma cell lines. GUT , 44 A48 - A48.

Brett, BT; Khan, K; Savage, K; Michaeli, D; Grimes, S; Pounder, RE; Dhillon, AP; (1999) The effect of antibodies raised against Gastrimmune (TM) on the proliferation of human pancreatic carcinoma cell lines. GASTROENTEROLOGY , 116 (4) A382 - A382.

Brett, BT; Savage, K; Khan, K; Michaeli, D; Grimes, S; Dhillon, AP; Pounder, RE; (1999) Expression of the CCKB gastrin receptor (CCK-BR) in human lymphomas and non neoplastic lymphnodes. GASTROENTEROLOGY , 116 (4) A382 - A382.

Brett, BT; Savage, K; Khan, K; Michaeli, D; Grimes, S; Williams, M; Dhillon, AP; (1999) Expression of CCKB gastrin receptor(CCK-BR)in human peripheral blood mononuclear cells(PBMCS-)from healthy subjects with known H-pylori (HP) status. GASTROENTEROLOGY , 116 (4) A594 - A594.

Bridgewater, JA; Nelstrop, AE; Rustin, GJ; Gore, ME; McGuire, WP; Hoskins, WJ; (1999) Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel. J Clin Oncol , 17 (2) pp. 501-508. 10.1200/JCO.1999.17.2.501.

Brimmell, M; Burns, JS; Munson, P; McDonald, L; O'Hare, MJ; Lakhani, SR; Packham, G; (1999) High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. BRITISH JOURNAL OF CANCER , 81 (6) pp. 1042-1051. 10.1038/sj.bjc.6690805.

Brock, CS; Davies, C; Ledermann, JA; Stein, RC; (1999) A pilot study of infusional chemotherapy FMM (5-fluorouracil, mitoxantrone, methotrexate) in advanced breast cancer. British Journal of Cancer , 80 p. 298.

Brock, CS; Davies, C; Ledermann, JA; Stein, RC; (1999) A pilot study of infusional chemotherapy FMM (5-fluorouracil, mitoxantrone, methotrexate) in advanced breast cancer. BRIT J CANCER , 80 103 - 103.

Brooks, N; McHugh, PJ; Lee, M; Hartley, JA; (1999) The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size. ANTI-CANCER DRUG DES , 14 (1) 11 - 18.

Brooks, N; Mchugh, PJ; Lee, M; Hartley, JA; (1999) Repair of DNA damage produced by sequence specific minor groove alkylating agent. PROC AM ASSOC CANCER RES , 40 p. 4118.

Buckley, CD; Pilling, D; Henriquez, NV; Parsonage, G; Threlfall, K; Scheel-Toellner, D; Simmons, DL; (1999) RGD peptides induce apoptosis by direct caspase-3 activation. pp. 534-539.

Burcombe, RJ; Ostler, PJ; Ayoub, AW; Hoskin, PJ; (1999) Staging CT scans in prostate cancer treatment: A retrospective audit. British Journal of Cancer , 80 p. 157.

C

CRT, ; Laskey, RA; Williams, GH; Coleman, N; (1999) Determination of cellular growth abnormality. WO/1999/021014.

CRT, ; Laskey, RA; Williams, GH; Krude, T; Stoeber, K; Mills, AD; (1999) A cell-free replication system and uses thereof. WO99/11776.

Calabrese, CR; Thomas, HD; Batey, MA; Boritzki, T; Zhang, K; White, AW; Curtin, NJ; (1999) Preclinical pharmacology of novel substituted benzimidazoles - potent inhibitors of poly (ADP-ribose) polymerase. Clinical Cancer Research , 5 543-.

Calvert, AH; Ghokul, S; Al-Azraqi, A; Wright, J; Lind, M; Bailey, N; Highley, M; (1999) Carboplatin and paclitaxel, alone and in combination: Dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene. SEMINARS IN ONCOLOGY , 26 (1) 90 - 94.

Calvert, AH; Hughes, AN; Calvert, PM; Plummer, RE; Highley, MS; (1999) MTA (LY231514) demonstrates clinical activity against malignant mesothelioma in a phase I combination trial with carboplatin. European Journal of Cancer , 35 1146-.

Calvert, AH; Sessa, C; Hughes, A; Jochim, U; Calvert, P; Ghielmini, M; Renard, J; (1999) Pharmacokinetics (PK) of BMS-184476, a new taxane analog, given weekly in patients with advanced malignancies. European Journal of Cancer , 35 1147-.

Calvert, H; (1999) MTA, a novel multitargeted antifolate, from preclinical to phase I and beyond: summary and conclusions. Semin Oncol , 26 (2 Suppl ) pp. 105-108.

Calvert, H; (1999) MTA: Summary and conclusions. SEMIN ONCOL , 26 (2) 105 - 108.

Calvert, H; (1999) An overview of folate metabolism: Features relevant to the action and toxicities of antifolate anticancer agents. SEMINARS IN ONCOLOGY , 26 (2) 3 - 10.

Calvert, PM; Highley, MS; Hughes, AN; Plummer, ER; Azzabi, AST; Verrill, MW; Camboni, MG; (1999) A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors. Clinical Cancer Research , 5 333-.

Calvert, PM; Highley, MS; Hughes, AN; Plummer, ER; Azzabi, AST; Verrill, MW; Camboni, MG; (1999) A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors. CLIN CANCER RES , 5 3796S - 3796S.

Campbell, PJ; Tirvengadum, MA; Pickering, W; Cohen, H; Ryan, KE; (1999) HEPTEST: a suitable method for monitoring heparin during pregnancy. Clin Lab Haematol , 21 (3) pp. 193-199.

Cannell, E; Mittnacht, S; (1999) Viral encoded cyclins. Semin Cancer Biol , 9 (3) pp. 221-229. 10.1006/scbi.1999.0090.

Caplin, ME; Clarke, P; Grimes, S; Dhillon, AP; Khan, K; Savage, K; Lewin, J; (1999) Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy. REGUL PEPTIDES , 84 (1-3) 81 - 89.

Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ; (1999) Increased levels of activated factor XII (FXIIa) in hyperlipidaemia. THROMB HAEMOSTASIS 729 - 729.

Cardigan, RA; McGloin, H; Mackie, IJ; Machin, SJ; Singer, M; (1999) Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. Kidney International , 55 (4) pp. 1568-1574.

Cardigan, RA; McGloin, H; Mackie, IJ; Machin, SJ; Singer, M; (1999) Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. KIDNEY INT , 55 (4) 1568 - 1574.

Casey, JL; Pedley, RB; King, DJ; Boden, R; Chapman, AP; Yarranton, GT; Begent, RHJ; (1999) Improved tumour targeting of di-Fab ' fragments modified with polyethylene glycol. TUMOR TARGET , 4 (4) 235 - 244.

Casey, JL; Pedley, RB; King, DJ; Boden, R; Chapman, AP; Yarranton, GT; Begent, RHJ; (1999) Improved tumour targeting of di-Fab' fragments modified with polyethylene glycol. Tumor Targeting , 4 (4) pp. 235-244.

Casey, JL; Pedley, RB; King, DJ; Green, AJ; Yarranton, GT; Begent, RH; (1999) Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments. Br J Cancer , 81 (6) pp. 972-980. 10.1038/sj.bjc.6690795.

Casey, JL; Pedley, RB; King, DJ; Green, AJ; Yarranton, GT; Begent, RHJ; (1999) Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments. BRIT J CANCER , 81 (6) 972 - 980.

Cassoni, AM; Whelan, JS; (1999) Ewing's sarcoma: hyperfractionated radiotherapy with concurrent chemotherapy: acute toxicity. A prospective single institutional study. In: (pp. p. 45).

Chakrabarti, S; Steven, N; Collingham, K; Cassellas, SA; Pillay, D; Kaur, N; Hale, G; (1999) Viral reactivation and immune reconstitution following Campath 1H and fludarabine based non-myeloablative conditioning for allogeneic stem cell transplantation compared to Campath-based T cell depletion regimens: A preliminary report. BLOOD , 94 (10) 153A - 153A.

Chakraverty, RK; Hickson, ID; (1999) Defending genome integrity during DNA replication: a proposed role for RecQ family helicases. Bioessays , 21 (4) pp. 286-294. 10.1002/(SICI)1521-1878(199904)21:4<286::AID-BIES4>3.0.CO;2-Z.

Chan, JK; Miller, KD; Munson, P; Isaacson, PG; (1999) Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method? Histopathology , 34 (3) pp. 266-270.

Chang, J; Powles, TJ; Allred, DC; Ashey, SE; Clark, GM; Makris, A; Assersohn, L; (1999) Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. Journal Of Clinical Oncology , 17 pp. 3058-3063.

Chester, KA; Melton, RG; Hawkins, RR; (1999) Phage technology for producing antibody enzyme fusion proteins. In: Melton, RG and Fox, RJ, (eds.) Enzyme-Prodrug Strategies for Cancer Therapy. Klewer Academic/Plenum Press

Chitolie, A; Mackie, IJ; Lawrie, AS; Donohue, S; Cohen, H; Machin, SJ; (1999) Evidence of ongoing thrombin generation in patients with prothrombin G -> A 20210 mutation. THROMB HAEMOSTASIS 551 - 552.

Cooke, SP; Pedley, RB; Boden, R; Holliger, P; Winter, G; Begent, RHJ; Chester, KA; (1999) Tumour targeting using MFE-23 :: TNF alpha fusion protein. BRIT J CANCER , 80 85 - 85.

Cooke, SP; Pedley, RB; Boden, R; Holliger, P; Winter, G; Begent, RHJ; Chester, KA; (1999) Tumour targeting using MFE-23::TNF alpha fusion protein. British Journal of Cancer , 80 p. 228.

Cooke, SP; Pedley, RBB; R, H; P, W; G, B; R H J and Chester, KA; (1999) Tumour targeting using MFE::TNF fusion protein. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 85-).

Cooooke, SP; Pedley, RB; Boden, R; Holliger, P; Winter, G; Begent, RHJ; Chester, KA; (1999) Tumour targeting using MFE-23::TNF alpha fusion protein. In: (Proceedings) British Journal of Cancer. (pp. p. 228).

Corell, A; Pay, AL; Arguello, JR; Borton, M; Dunne, C; Madrigal, JA; Marsh, SGE; (1999) RSCA (reference strand mediated conformation analysis) resolves HLA-DRB1*04 typing ambiguities where other molecular techniques fail. BLOOD , 94 (10) 318B-318B.

Cox, ST; Arguello, JR; Marsh, SGE; Lau, M; Kwan, PL; Madrigal, JA; Little, AM; (1999) Sequence of HLA-A*6808. TISSUE ANTIGENS , 53 (6) pp. 597-600. 10.1034/j.1399-0039.1999.530614.x.

Cox, ST; Marsh, SGE; Scott, I; Clayton, J; Arguello, JR; McWhinnie, AJ; Prokupek, B; (1999) HLA-A, -B, -C polymorphism in a UK Ashkenazi Jewish potential bone marrow donor population. TISSUE ANTIGENS , 53 (1) pp. 41-50. 10.1034/j.1399-0039.1999.530105.x.

Crawford, J; Ianzano, L; Savino, M; Whitmore, S; Cleton-Jansen, AM; Settasatian, C; d'Apolito, M; (1999) The PISSLRE gene: Structure, exon skipping, and exclusion as tumor suppressor in breast cancer. GENOMICS , 56 (1) 90 - 97.

Cullen, M; Hancock, BW; Gregory, WM; Hudson, GV; Burton, A; Selby, P; Maclennan, KA; (1999) Ch1VPP/PABIOE is superior to PABIOE: Interim results of the British national lymphoma investigation/central lymphoma group randomised trial in advanced Hodgkin's disease. BRIT J CANCER , 80 18 - 18.

Cummins, D; Hoskin, P; Young, J; Goodman, IL; Coupe, MO; Halil, O; Foy, CJ; (1999) Is a man's facial appearance predictive of how he will die? International Journal of Clinical Practice , 53 pp. 140-141.

Curtin, NJ; Bowman, KJ; Turner, RN; Huang, B; Loughlin, PJ; Calvert, AH; Golding, BT; (1999) Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha(1)-acid glycoprotein binding. BRIT J CANCER , 80 (11) 1738 - 1746.

Curtin, NJ; Kyle, S; Wang, LZ; Durkacz, BW; White, AJ; Srinivasan, S; Griffin, RJ; (1999) Potentiation of temozolomide and topotecan growth inhibition by novel potent benzimidazole poly(ADP-ribose) polymerase (PARP) inhibitors. Clinical Cancer Research , 5 520-.

Curtin, NJ; Kyle, S; Wang, LZ; Durkacz, BW; White, AJ; Srinivasan, S; Griffin, RJ; (1999) Potentiation of temozolomide and topotecan growth inhibition by novel potent benzimidazole poly(ADP-ribose) polymerase (PARP) inhibitors. CLIN CANCER RES , 5 3834S - 3834S.

D

D'Sa, S; Verfuerth, S; Vyas, P; Langabeer, S; Perry, A; Peniket, A; Mackinnon, S; (1999) Early PCR-negativity after allogeneic BMT in adults with t(4;11) ALL in the absence of acute or chronic GVHD. BONE MARROW TRANSPL , 23 (7) 695 - 696.

Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Wales, JKH; Hindmarsh, PC; (1999) HESX1: a novel gene implicated in a familial form of septo-optic dysplasia. ACTA PAEDIATRICA , 88 49 - 54.

De Silva, IU; Clingen, PH; McHugh, PJ; Tilby, MJ; Gregson, SJ; Howard, P; Thurston, DE; (1999) The role of nucleotide excision repair in the repair of DNA damage induced by mono- and bifunctional, major and minor groove alkylating agents. BRIT J CANCER , 80 42 - 42.

DeMartini, JC; Halsey, W; Boshoff, C; York, D; Howell, MD; (1999) Comparison of a maedi-visna virus CA-TM fusion protein ELISA with other assays for detecting sheep infected with North American ovine lentivirus strains. VET IMMUNOL IMMUNOP , 71 (1) 29 - 40.

DeSilva, IU; Clingen, PH; Mchugh, PJ; Tilby, MJ; Gregson, SJ; Howard, P; Thurston, DE; (1999) The role of nucleotide excision repair in the repair of DNA damage induced by mono- and bifunctional, major and minor groove alkylating agents. British Journal of Cancer , 80 p. 55.

Deighton, A; Winfield, EA; Venables, K; Aird, EGA; Hoskin, PJ; (1999) Variation in dose distribution for breast radiotherapy: A trial based quality assurance programme in the UK. European Journal of Cancer , 35 p. 342.

Delaney, CA; Wang, LZ; Kyle, LZ; Srinivasan, S; White, AW; Curtin, NJ; Calvert, AH; (1999) Potentiation of temozolomide and topotecan cytotoxicity by PARP inhibitors in a panel of human cancer cell lines. British Journal of Cancer , 80 62-.

Delaney, CA; Wang, LZ; Kyle, LZ; Srinivasan, S; White, AW; Curtin, NJ; Calvert, AH; (1999) Potentiation of temozolomide and topotecan cytotoxicity by PARP inhibitors in a panel of human cancer cell lines. BRIT J CANCER , 80 44 - 44.

Delassus, S; Titley, I; Enver, T; (1999) Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. BLOOD , 94 (5) pp. 1495-1503.

Delecluse, HJ; Hummel, M; Marafioti, T; Anagnostopoulos, I; Stein, H; (1999) Common and HIV-related diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern. J Pathol , 188 (2) pp. 133-138. 10.1002/(SICI)1096-9896(199906)188:2<133::AID-PATH349>3.0.CO;2-Y.

Devereux, S; Corney, C; Macdonald, C; Watts, M; Ward, M; Bank, A; Linch, DC; (1999) Multi-drug resistance (MDR-1) gene transfer in patients with poor prognosis lymphoma undergoing high dose therapy and CD34 selected peripheral blood stem cell transplantation (PBSCT). BONE MARROW TRANSPL , 23 S85 - S85.

Dhanjal, S; Macdonald, F; Roberts, E; Davison, V; Grimshaw, G; Szczepura, A; Hulten, M; (1999) Molecular diagnosis of the common chromosomal aneuploidies. J MED GENET , 36 S54 - S54.

Diehl, V; Sextro, M; Franklin, J; Hansmann, ML; Harris, N; Jaffe, E; Poppema, S; (1999) Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol , 17 (3) pp. 776-783. 10.1200/JCO.1999.17.3.776.

Dische, S; Saunders, MI; (1999) The CHART regimen and morbidity [Full text available, price (Pounds)16.45]. Acta Oncologica , 38 pp. 147-152.

Dische, S; Saunders, MI; Sealy, R; Werner, ID; Verma, N; Foy, C; Bentzen, SM; (1999) Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial. Radiotherapy and Oncology , 53 pp. 93-98.

Diss, TC; Du, MQ; Peng, HZ; Parkinson, MC; Kerr, J; (1999) Parovirus B19 is associated with benign testicular tissue as well as testicular germ cell tumours. Molecular Pathology , 52 (6) pp. 349-352.

Donohoe, S; Geary, M; Kingdom, JCP; Jauniaux, E; Purdy, G; Mackie, IJ; (1999) Maternal cardiolipin, beta(2)-glycoprotein-I and prothrombin antibody expression in high-risk pregnancies with bilateral abnormal uterine artery Doppler waveforms. ULTRASOUND OBST GYN , 13 (5) 317 - 322.

Donohoe, S; Kingdom, J; Mackie, I; Jauniaux, E; Machin, S; (1999) beta(2)GPI and Annexin V in normal and APS villous placenta. BRIT J HAEMATOL , 105 28 - 28.

Donohoe, S; Kingdom, JCP; Mackie, IJ; (1999) Affinity purified human antiphospholipid antibodies bind normal term placenta. LUPUS , 8 (7) 525 - 531.

Donohoe, S; Mackie, I; Kingdom, J; Jauniaux, E; Machin, S; (1999) Placental expression of beta(2)GPI and annexin V in normal and APS pregnancies. THROMB HAEMOSTASIS 66 - 66.

Dowsett, M; Smith, IE; Powles, TJ; Salter, J; Ellis, PM; Johnston, SRD; Makris, A; (1999) Biological studies in primary medical therapy of breast cancer: The Royal Marsden Hospital experience. In: Howell, A and Dowsett, M, (eds.) ESO Scientific Updates. (pp. 113-125). Elsevier Science

Du, MQ; Isaacson, PG; (1999) Genesis and progression of gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Molecular Biology of Haematopoesis , 6 pp. 203-212.

Dunham, I; Shimizu, N; Roe, BA; Chissoe, S; Dunham, I; Hunt, AR; Collins, JE; (1999) The DNA sequence of human chromosome 22. NATURE , 402 (6761) 489 - 495.

Dupin, N; Fisher, C; Kellam, P; Ariad, S; Tulliez, M; Franck, N; van Marck, E; (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. P NATL ACAD SCI USA , 96 (8) 4546 - 4551.

Duro, D; Schulze, A; Vogt, B; Bartek, J; Mittnacht, S; Jansen-Dürr, P; (1999) Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8. J Gen Virol , 80 ( P pp. 549-555. 10.1099/0022-1317-80-3-549.

Dutt, N; Bates, AW; Baithun, SI; (1999) Secondary tumours of the testis: a clinico-pathological study of 31 cases. J PATHOL , 189 18A - 18A.

Dyer, MJS; Price, H; Jadayel, DM; Gasco, M; Perry, AR; Hamoudi, RA; Willis, TG; (1999) Absence of bcl-10 mutations in human malignant mesothelioma in reponse to Fakruddin et al and Apostolou et al. Cell , 97 pp. 686-688.

E

Eardley, K; Majumdar, A; Ferrreira, MAS; Howie, AJ; Richards, NT; Savage, COS; Wheeler, DC; (1999) Microalbuminuria as a predictor of glomerular disease and renal prognosis in patients with microscopic haematuria. KIDNEY INT , 55 (6) 2586 - 2586.

Ellis, BL; Sampson, CB; Abeysinghe, RD; Porter, JB; Hider, RC; (1999) 6-Alkoxymethyl-3-hydroxy-4H-pyranones: potential ligands for cell-labelling with indium. Eur J Nucl Med , 26 (11) pp. 1400-1406.

Ellis, M; Chew, YP; Fallis, L; Freddersdorf, S; Boshoff, C; Weiss, RA; Lu, X; (1999) Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J , 18 (3) 644 - 653.

Enver, T; (1999) B-cell commitment: Pax5 is the deciding factor. CURRENT BIOLOGY , 9 (24) R933-R935. 10.1016/S0960-9822(00)80108-6.

Espada, J; Perez-Moreno, M; Braga, VMM; Rodriguez-Viciana, P; Cano, A; (1999) H-ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J CELL BIOL , 146 (5) 967 - 980.

F

Falzetti, D; Vermeesch, JR; Hood, TL; Nacheva, EP; Matteucci, C; Martelli, MF; Van den Berghe, H; (1999) Identification of multiple copies of a 20q-chromosome in a case of myelodysplastic syndrome: a FISH study. LEUKEMIA RES , 23 (4) 407 - 413.

Fielding, A; Bateman, A; Vile, R; Cosset, FL; Russell, S; (1999) Targeting the cytotoxicity of a fusogenic gibbon ape leukaemia virus envelope glycoprotein by ligand display. GENE THERAPY , 6 S8-S8.

Fierabracci, A; Hammond, L; Lowdell, M; Chiovato, L; Goode, AW; Bottazzo, GF; Mirakian, R; (1999) The effect of staphylococcal enterotoxin B on thyrocyte HLA molecule expression. J Autoimmun , 12 (4) pp. 305-314. 10.1006/jaut.1999.0279.

Fischer, G; Arguello, JR; Perez-Rodriguez, M; Cox, ST; McWhinnie, A; Marsh, SGE; Madrigal, JA; (1999) Novel intronic variants of MICB (MHC class I chain-related gene B). EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (6) pp. 399-404. 10.1046/j.1365-2370.1999.00182.x.

Fischer, G; Perez-Rodriguez, M; Arguello, JR; McWhinnie, A; Marsh, SGE; Travers, PJ; Madrigal, JA; (1999) Associations of MICB with MICA and HLA-B - Implications for the development of graft-versus-host-disease? BLOOD , 94 (10) 367B-367B.

Flynn, AA; Green, AJ; Boxer, G; Pedley, RB; Begent, RH; (1999) A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology. Phys Med Biol , 44 (7) N151-N159.

Flynn, AA; Green, AJ; Boxer, G; Pedley, RB; Begent, RHJ; (1999) A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology. PHYS MED BIOL , 44 (7) N151 - N159.

Flynn, AA; Green, AJ; Boxer, GM; Casey, JL; Pedley, RB; Begent, RHJ; (1999) A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model. INT J RADIAT ONCOL , 43 (1) 183 - 189.

Freeman, A; Morris, LS; Mills, AD; Stoeber, K; Laskey, RA; Williams, GH; Coleman, N; (1999) Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. CLIN CANCER RES , 5 (8) 2121 - 2132.

Freeman, AA; Stoeber, K; Morris, LS; Williams, GH; Laskey, RA; Coleman, N; (1999) New biological markers for dysplasia. J PATHOL , 187 22A - 22A.

Frohlich, B; Paulussen, M; Craft, A; Judson, I; Ladenstein, R; Oberlin, O; Whelan, JS; (1999) Therapiekonzepte bei non-responden/rezidivpatienten mit Eing Sarkomen im kindesalter. In:

G

GUPTA, R; Abdalla, SH; Bain, BJ; (1999) Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome. Leukemia & Lymphoma , 34 (5-6) pp. 615-619.

Gale, RE; (1999) Evaluation of clonality in myeloid stem-cell disorders. SEMIN HEMATOL , 36 (4) 361 - 372.

Gale, RE; Forbes, LV; Pizzey, A; Pouwels, K; Linch, DC; (1999) A leukemia-associated mutation in the G-CSF receptor implies a role for the transmembrane domain in receptor activation. BLOOD , 94 (10) 45A - 45A.

Gan, TJ; Bennett-Guerrero, E; Phillips-Bute, B; Wakeling, H; Moskowitz, DM; Olufolabi, Y; Konstadt, SN; (1999) Hextend (R), a physiologically balanced plasma expander for large volume use in major surgery: A randomized phase III clinical trial. In: ANESTHESIA AND ANALGESIA. (pp. 992 - 998). LIPPINCOTT WILLIAMS & WILKINS

Gander, M; Hartley, JM; Spanswick, VJ; Webley, SD; Hochhauser, D; Hartley, JA; (1999) Measurment of DNA interstrand crosslinking in clinical samples using the single cell gel electrophoresis. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH , 40 p. 3410.

Garcia, SB; Park, HS; Novelli, M; Wright, NA; ', ; (1999) Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. The Journal of Pathology , 187 (1) pp. 61-81.

Gardiner, C; Harrison, P; Chavda, N; Mackie, IJ; Machin, SJ; (1999) Platelet activation responses in vitro to human mast cell activation. BRIT J HAEMATOL , 106 (1) 208 - 215.

Gardiner, C; Harrison, P; Chavda, N; Mackie, IJ; Machin, SJ; (1999) Platelet aggregation in response to in vitro human mast cell activation. THROMB HAEMOSTASIS 461 - 461.

Gardiner, C; Mackie, IJ; Machin, S; Malia, RG; Jones, DW; Winter, M; Taberner, D; (1999) The impact of different DRVVT calculation methods on lupus anticoagulant testing. British Journal of Haematology , 105 p. 7.

Gardiner, C; Mackie, IJ; Machin, SJ; Taberner, D; Leeming, D; Malia, RG; Jones, DW; (1999) Modification of DRVVT calculation methods improves the specificity of lupus anticoagulants. THROMB HAEMOSTASIS 587 - 587.

Gerhard, DS; Xu, Z; Nguyen, L; Li, Y; Mungall, A; Beck, S; Huettner, P; (1999) The generation of a sequence-ready contig encompassing the cervical tumor suppressor gene (TSG) on 6p23. AM J HUM GENET , 65 (4) A127 - A127.

Ghazal-Aswad, S; Tilby, MJ; Lind, M; Baily, N; Sinha, DP; Calvert, AH; Newell, DR; (1999) Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels. ANN ONCOL , 10 (3) 329 - 334.

GlynneJones, R; Saunders, MI; Hoskin, P; Phillips, H; (1999) A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinoma. Clinical Oncology , 11 pp. 334-339.

Goodchild, K; Hoskin, P; Dische, S; Pigott, K; Powell, M; Saunders, M; (1999) A feasibility study of continuous hyperfractionated accelerated radiotherapy (CHART) and brachytherapy in patients with early oral or oropharyngeal carcinomas. Radiotherapy and Oncology , 50 pp. 29-31.

Goodchild, KA; Hill, SA; Hoskin, PJ; Saunders, MI; Chaplin, DJ; (1999) Low dose nicotinamide and carbogen improve human tumour blood flow. British Journal of Cancer , 80 p. 244.

Gooding, RP; Bybee, A; Cooke, F; Little, A; Marsh, SGE; Coelho, E; Gupta, D; (1999) Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia. BRITISH JOURNAL OF HAEMATOLOGY , 106 (3) pp. 669-681. 10.1046/j.1365-2141.1999.01602.x.

Gorodetsky, R; Lotan, C; Piggot, K; Pierce, LJ; Polyansky, I; Dische, S; Saunders, MI; (1999) Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. International Journal of Radiation Oncology Biology Physics , 45 pp. 893-900.

Gosriwatana, I; Loreal, O; Lu, S; Brissot, P; Porter, J; Hider, RC; (1999) Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. ANAL BIOCHEM , 273 (2) 212 - 220.

Goulis, J; Chau, TN; Jordan, S; Mehta, AB; Watkinson, A; Rolles, K; Burroughs, AK; (1999) Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut , 44 (5) pp. 754-758.

Grassilli, E; Salomoni, P; Perrotti, D; Franceschi, C; Calabretta, B; (1999) Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. CANCER RES , 59 (10) 2451 - 2456.

Gray, E; Mackie, I; Greaves, M; (1999) Calibration of the 1st British reference plasmas panel for lupus anticoagulants. BRIT J HAEMATOL , 105 97 - 97.

Gray, E; Mackie, I; Greaves, M; (1999) A strategy for improving the quality of lupus anticoagulant testing: Establishment of the 1st British Reference Plasmas Panel for Lupus Anticoagulant. THROMB HAEMOSTASIS 67 - 67.

Green, AJ; Adamson, KL; Begent, RH; (1999) Validation of a gamma camera PET system for serial 18F-FDG imaging for the measurement of response to anti-cancer therapies. Journal of Nuclear Medicine , 40 p. 1246.

Gribble, S; Andrews, K; Williams, D; Grace, CD; Green, AR; Nacheva, EP; (1999) Two telomeres detected by FISH in the short arm of a marker derived from chromosome 16 in an infant with thrombocytopenia. CYTOGENET CELL GENET , 85 (1-2) 37 - 37.

Gribble, SM; Roberts, I; Grace, C; Green, AR; Nacheva, EP; (1999) M-FISH and CGH analysis of 10 CML derived cell lines; identification of a common region of amplification on the long arm of chromosome 8. CYTOGENET CELL GENET , 85 (1-2) 38 - 38.

Gribble, SM; Sinclair, PB; Grace, C; Green, AR; Nacheva, EP; (1999) Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis. In: CANCER GENET CYTOGEN. (pp. 7 - 17). ELSEVIER SCIENCE INC

Griffin, RJ; Barlow, HC; Curtin, NJ; Calvert, AH; Golding, BT; Newell, DR; Smith, PG; (1999) 2,6-Disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines as nucleoside transport inhibitors: Structure-activity relationships for binding to alpha(1)-acid glycoprotein (AGP). Clinical Cancer Research , 5 564-.

Griffin, RJ; Barlow, HC; Curtin, NJ; Calvert, AH; Golding, BT; Newell, DR; Smith, PG; (1999) 2,6-Disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines as nucleoside transport inhibitors: Structure-activity relationships for binding to alpha(1)-acid glycoprotein (AGP). CLIN CANCER RES , 5 3843S - 3843S.

Griffioen, A; Sabin, CA; Devereux, H; Yee, TT; Lee, CA; (1999) Natural history of hepatitis C virus in a cohort of individuals with clotting factor disorders treated with unsterilised clotting concentrates. THROMB HAEMOSTASIS 475 - 476.

Griffioen, A; Sabin, CA; Devereux, H; Yee, TT; Lee, CA; (1999) Natural history of hepatitis C virus in a cohort of individuals with clotting factor disorders treated with unsterilised clotting concentrates. BRIT J HAEMATOL , 105 50 - 50.

Grimaldi, KA; Bingham, JP; Hartley, JA; (1999) PCR-based assays for strand-specific measurement of DNA damage and repair. I. Strand-specific quantitative PCR. Methods Mol Biol , 113 pp. 227-240. 10.1385/1-59259-675-4:227.

Grimaldi, KA; Bingham, JP; Hartley, JA; (1999) PCR-Based Assys for Strand-Specific Measurement of DNA Damage and Repair I. In: Henderson, DS, (ed.) Methods in Molecular Biology. (pp. 227-241). Humana Press Inc

Grimaldi, KA; Mac Adam, SR; Hartley, JA; (1999) PCR-Based Assys for Strand-Specific Measurement of DNA Damage and Repair II. In: Henderson, DS, (ed.) Methods in Molecular Biology. (pp. 241-255). Humana Press

Grimaldi, KA; McAdam, SR; Hartley, JA; (1999) PCR-based assays for strand-specific measurement of DNA damage and repair. II. Single-strand ligation-PCR. Methods Mol Biol , 113 pp. 241-255. 10.1385/1-59259-675-4:241.

Guo, AL; Zhong, S; Ronchetti, S; Ruggero, D; Salomoni, P; Pandolfi, PP; (1999) PML is required for the ability of DAXX to regulate programmed cell death. BLOOD , 94 (10) 489A - 489A.

H

Hackshaw, A; Wald, NJ; Ayme, A; (1999) Statement from panel on antenatal screening for Down syndrome. In: Beazoglou, T and Benn, P and Cuckle, H and Haddow, J and Kyriopoulos, J, (eds.) Down syndrome: Screening policy and economic evaluations. (pp. 261-265). National School of Public Health, Exandus Publishers, Athens

Hamdulay, SS; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (1999) Differential expression of the alternatively spliced STAT-1 alpha and beta mRNA and its products in B-CLL and tonsillar B-cells. BRIT J HAEMATOL , 105 86 - 86.

Hargreaves, RHJ; O'Hare, CC; Hartley, JA; Ross, D; Butler, J; (1999) Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents. J MED CHEM , 42 (12) 2245 - 2250.

Harris, NL; Isaacson, PG; (1999) What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? American Journal of Clinical Pathology , 111 (1 supp) S126-S132.

Harrison, CN; Gale, RE; Machin, SJ; Linch, DC; (1999) A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. BLOOD , 93 (2) 417 - 424.

Harrison, CN; Gale, RE; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Essential thrombocythaemia with polyclonal haemopoiesis is not due to disruption in levels of interleukins-6,-11, thrombopoietin, or transforming growth factor beta 1 levels. BLOOD , 94 (10) 112A - 112A.

Harrison, CN; Gale, RE; Pezella, F; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. British Journal of Haematology , 107 (1) pp. 139-147. 10.1046/j.1365-2141.1999.01667.x.

Harrison, CN; Gale, RE; Pezella, F; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. BRIT J HAEMATOL , 107 (1) 139 - 147.

Harrison, CN; Gale, RE; Pezzella, F; Mire-Sluis, A; Machin, SJ; Linch, DC; (1999) Platelet c-mpl expression and plasma thrombopoietin levels are dysregulated in patients with thrombocytosis; regardless of clonal status. British Journal of Haematology , 107 pp. 139-147.

Harrison, CN; Gregory, W; Hudson, GV; Devereux, S; Goldstone, AH; Hancock, B; Winfield, D; (1999) High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. BRIT J CANCER , 81 (3) 476 - 483.

Harrison, P; Robinson, M; Khair, K; Liesner, R; Carr, P; Criddle, S; Mackie, I; (1999) The PFA-100(R) - A potential screening tool for the assessment of platelet dysfunction. THROMB HAEMOSTASIS 743 - 743.

Harrison, P; Robinson, MSC; Mackie, IJ; Joseph, J; McDonald, SJ; Liesner, R; Savidge, GF; (1999) Performance of the platelet function analyser PFA-100 (R) in testing abnormalities of primary haemostasis. BLOOD COAGUL FIBRIN , 10 (1) 25 - 31.

Harrison, P; Robinson, MSC; Mackie, IJ; Joseph, J; McDonald, SJ; Liesner, R; Savidge, GF; (1999) Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis. Blood Coagulation and Fibrinolysis , 10 (1) pp. 25-31.

Hartley, JA; O'Hare, CC; Baumgart, J; (1999) DNA alkylation and interstrand cross-linking by treosulfan. BRIT J CANCER , 79 (2) 264 - 266.

Hartley, JM; Spanswick, VJ; Gander, M; Giacomini, G; Whelan, J; Souhami, RL; Hartley, JA; (1999) Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. CLIN CANCER RES , 5 (3) 507 - 512.

Haynes, AP; Kottiridis, P; Byrne, JL; Goldstone, A; Russell, NH; Linch, DC; McKinnon, S; (1999) Results of allogeneic transplantation for lymphoma - A report on 41 patients. BRIT J HAEMATOL , 105 87 - 87.

Hennesey, BJ; Mehta, AB; Kibbler, C; Hoffbrand, AV; (1999) Case Report: Candida glabrata fungal ball in the oesophagus. CME Bulletin Haematology , 2 pp. 100-101.

Henriquez, NV; Floettmann, E; Salmon, M; Rowe, M; Rickinson, AB; (1999) Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1. pp. 3298-3307.

Heppell-Parton, AC; Nacheva, E; Carter, NP; Bergh, J; Ogilvie, D; Rabbitts, PH; (1999) Elucidation of the mechanism of homozygous deletion of 3p12-13 in the U2020 cell line reveals the unexpected involvement of other chromosomes. Cancer Genet Cytogenet , 111 (2) pp. 105-110.

Heppell-Parton, AC; Nacheva, E; Carter, NP; Rabbitts, PH; (1999) A combined approach of conventional and molecular cytogenetics for detailed karyotypic analysis of the small cell lung carcinoma cell line U2020. Cancer Genet Cytogenet , 108 (2) pp. 110-119.

Heyworth, C; Gale, K; Dexter, M; May, G; Enver, T; (1999) A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal. GENES & DEVELOPMENT , 13 (14) pp. 1847-1860. 10.1101/gad.13.14.1847.

Hillan, KJ; Hagler, KE; MacSween, RNM; Ryan, AM; Renz, ME; Chiu, HH; Ferrier, RK; (1999) Expression of the mucosal vascular addressin MAdCAM-1, in inflammatory liver disease. LIVER , 19 (6) 509 - 518.

Hillmen, P; Richards, SJ; Baker, AJ; Gale, RE; Rawstron, AC; Crawford, DH; Lalloz, MRA; (1999) Congenital paroxysmal nocturnal haemoglobinuria. BRIT J HAEMATOL , 105 64 - 64.

Hochhauser, D; (1999) Cancer researchers get down to arrays at AACR. LANCET , 353 (9162) 1418 - 1418.

Hochhauser, D; Valkov, NI; Gump, JL; Wei, I; O'Hare, C; Hartley, J; Fan, JG; (1999) Effects of wild-type p53 expression on the quantity and activity of topoisomerase II alpha and beta in various human cancer cell lines. J CELL BIOCHEM , 75 (2) 245 - 257.

Holmes, Z; Backos, M; Atoyebi, W; Pickering, W; Regan, L; Cohen, H; (1999) Screening for heritable thrombophilic risk factors in a recurrent miscarriage population. In: THROMB HAEMOSTASIS. (pp. 534 - 535). F K SCHATTAUER VERLAG GMBH

Holmes, Z; Backos, M; Atoyebi, W; Pickering, W; Regan, L; Cohen, H; (1999) Screening for heritable thrombophilic risk factors in a recurrent miscarriage population. In: BRIT J HAEMATOL. (pp. 45 - 45). BLACKWELL SCIENCE LTD

Holmes, ZR; Regan, L; Chilcott, I; Cohen, H; (1999) The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. BRIT J HAEMATOL , 105 (1) 98 - 101.

Hoskin, PJ; Abdelath, O; Phillips, H; Gilligan, S; Saunders, MI; Broderick, P; Baddeley, H; (1999) Inspired and expired gas concentrations in man during carbogen breathing. Radiotherapy and Oncology , 51 pp. 175-177.

Hoskin, PJ; Saunders, MI; Abdellati, O; Broderick, P; (1999) Capnometry and blood gas measurements in man during carbogen breathing. British Journal of Cancer , 80 p. 328.

Hoskin, PJ; Saunders, MI; Dische, S; (1999) Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma - Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Cancer , 86 pp. 1322-1328.

Hoskin, PJ; Saunders, MI; Goodchild, K; Powell, MEB; Taylor, NJ; Baddeley, H; (1999) Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. British Journal of Radiology , 72 pp. 1093-1098.

Hoskin, PJ; Stratford, M; Folkes, L; Phillips, H; Jackson, S; Regan, J; Yarnold, JR; (1999) Bone markers in response to local radiotherapy for bone pain. British Journal of Cancer , 80 p. 28.

Hsieh, JK; Chan, FS; O'Connor, DJ; Mittnacht, S; Zhong, S; Lu, X; (1999) RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell , 3 (2) pp. 181-193.

Hughes, A; Calvert, H; (1999) An update on thymidylate synthase inhibitors. ANN ONCOL , 10 (10) 1137 - 1139.

Hughes, AN; Rafi, I; Griffin, MJ; Calvert, AH; Newell, DR; Calvete, JA; Johnston, A; (1999) Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days. CLIN CANCER RES , 5 (1) 111 - 118.

Hummel, M; Marafioti, T; Stein, H; (1999) Clonality of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med , 340 (5) pp. 394-395. 10.1056/NEJM199902043400518.

Hunalov, A; Robson, L; Perkins, SJ; Begent, RHJ; Chester, KA; (1999) A vector for expression of dimeric and chelating forms of anti-CEA scFvS. British Journal of Cancer , 80 p. 92.

Hunalov, A; Robson, L; Perkins, SJ; Begent, RHJ; Chester, KA; (1999) A vector for expression of dimeric and chelating forms of anti-CEA scFvS. BRIT J CANCER , 80 51 - 51.

I

Ings, SJ; Schey, S; Hancock, B; Watts, MJ; Vandenberghe, E; Goldstone, AH; Elston, T; (1999) Results of a BNLI randomized trial of G-CSF dose after cyclophosphamide 1.5g/m(2) for progenitor cell mobilization. BLOOD , 94 (10) 666A - 666A.

Isaacson, PG; (1999) Gastric MALT lymphoma: from concept to cure. Annals of Oncology , 10 (6) pp. 637-645.

Isaacson, PG; (1999) Gastrointestinal lymphomas of T- and B-cell types. Modern Pathology , 12 (2) pp. 151-158.

Isaacson, PG; (1999) Mucosa associated lymphoid tissue lymphoma. Seminars in Hematology , 36 (2) pp. 139-147.

Isaacson, PG; (1999) T-cell lymphoma: the real thing. Human Pathology , 45 (5) p. 639.

Isaacson, PG; Diss, TC; Wotherspoon, AC; Barbazza, R; Boni, M; Doglioni, C; (1999) Long-term follow-up of gastric MALT lymphoma treated by eradication of H pylori with antibodies. Gastroenterology , 117 (3) pp. 750-751.

J

Janitz, K; Wild, A; Beck, S; Savasta, S; Beluffi, G; Ziegler, A; Volz, A; (1999) Genomic organization of the HSET locus and the possible association of HLA-linked genes with immotile cilia syndrome (ICS). IMMUNOGENETICS , 49 (7-8) 644 - 652.

Jennings, BH; Tyler, DM; Bray, SJ; (1999) Target Specificities of Enhancer of split Basic helix-loop-helix proteins in Drosophila. MCB , 19 pp. 4600-4610.

Johnson, PWM; Swinbank, K; MacLennan, S; Colomer, D; Debuire, B; Diss, T; Gabert, J; (1999) Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study. Annals of Oncology , 10 (11) pp. 1349-1354. 10.1023/A:1008385924543.

Joiner, MC; Marples, B; Lambin, P; Short, S; Turesson, I; (1999) Low-dose hypersensitivity: current status and possible mechanisms. International Journal of Radiation Oncology Biology Physics , 49 (2) pp. 379-389.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (1999) The putative role of Fas and caspase 8 in the killing of B-CLL cells by cytotoxic drugs and radiation. BLOOD , 94 (10) 310A - 310A.

Jones, DT; Wickremasinghe, RG; Mehta, AB; Prentice, HG; Hoffbrand, AV; Ganeshaguru, K; (1999) The putative role of induced Fas expression in the killing of B-CLL cells by DNA damaging agents. BRIT J HAEMATOL , 105 90 - 90.

Jones, DW; Joseph, JE; Donohoe, S; Mackie, IJ; Gallimore, MJ; Winter, M; (1999) Factor XII antibodies in patients with phospholipid antibodies: Are they predictors of thrombotic risk? THROMB HAEMOSTASIS 66 - 67.

Joseph, JE; Harrison, P; Mackie, IJ; Machin, SJ; (1999) Platelet activation and platelet-leukocyte complexes in the primary antiphospholipid syndrome (PAPS) and systemic lupus erythematosus (SLE). THROMB HAEMOSTASIS 68 - 69.

Joseph, JE; Mackie, IJ; Harrison, P; Machin, SJ; (1999) Increased thrombin generation in patients with the primary antiphospholipid syndrome. BRIT J HAEMATOL , 105 44 - 44.

K

Kaufman, J; Jacob, J; Shaw, I; Walker, B; Milne, S; Beck, S; Salomonsen, J; (1999) Gene organisation determines evolution of function in the chicken MHC. IMMUNOL REV , 167 101 - 117.

Kaufman, J; Milne, S; Gobel, TWF; Walker, BA; Jacob, JP; Auffray, C; Zoorob, R; (1999) The chicken B locus is a minimal essential major histocompatibility complex. NATURE , 401 (6756) 923 - 925.

Kellam, P; Bourboulia, D; Dupin, N; Shotton, C; Fisher, C; Talbot, S; Boshoff, C; (1999) Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8. J VIROL , 73 (6) 5149 - 5155.

Keshtgar, M; Kocjan, G; Saunders, C; Davidson, T; Baum, M; Ell, PJ; Taylor, I; (1999) Role of imprint cytology in sentinel node biopsy for breast cancer. BRIT J CANCER , 80 101 - 101.

Keshtgar, MRS; Kocjan, G; Ell, PJ; Taylor, I; (1999) A pain free approach to surgical oncology. In: (pp. p. 666).

Keshtgar, MRS; Kocjan, G; Lakhani, S; Taylor, I; Ell, PJ; (1999) Role of imprint cytology in sentinel node biopsy for breast cancer. European Journal of Nuclear Medicine , 8 pp. 152-153.

Keshtgar, MRS; Kocjan, G; Lakhani, SR; Ell, PJ; (1999) Imprint cytology in sentinel node biopsy in breast cancer: Is it reliable? In: (pp. S0107-).

Keshtgar, MRS; Kocjan, G; Lakhani, SR; Ell, PJ; (1999) Imprint cytology in sentinel node biopsy in breast cancer: Is it reliable? EUR J NUCL MED , 26 (4) S56 - S56.

Keshtgar, MRS; Kocjan, G; Lakhani, SR; Ell, PJ; (1999) Is imprint cytology reliable in sentinel node biopsy for breast cancer? In: (pp. p. 1115).

Keshtgar, MRS; Kocjan, G; Lakhani, SR; Ell, PJ; (1999) Is imprint cytology reliable in sentinel node biopsy for breast cancer? J NUCL MED , 40 (5) 251P - 252P.

Keshtgar, MRS; Kocjan, G; Saunders, C; Davidson, T; Baum, M; Taylor, I; Ell, PJ; (1999) Role of impact cytology in sentinel node biopsy for breast cancer. In: EUR J NUCL MED. (pp. 1006 - 1006). SPRINGER VERLAG

Khwaja, A; (1999) Akt is more than just a Bad kinase. Nature , 401 (6748) pp. 33-34. 10.1038/43354.

Khwaja, A; (1999) Apoptosis - Akt is more than just a Bad kinase. NATURE , 401 (6748) 33 - 34.

Khwaja, A; Hassan, R; Tatton, EL; Watts, M; Linch, DC; (1999) Inhibition of myeloid cell apoptosis by G-CSF and GM-CSF involves different signal transduction pathways depending on the stage of differentiation. BRIT J HAEMATOL , 105 102 - 102.

Khwaja, A; Tatton, L; (1999) Caspase-mediated proteolysis and activation of protein kinase C delta plays a central role in neutrophil apoptosis. BLOOD , 94 (1) 291 - 301.

Khwaja, A; Tatton, L; (1999) Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J BIOL CHEM , 274 (51) 36817 - 36823. Gold open access

Kiani-Alikhan, S; Chester, KA; Ledermann, JA; Beverley, PCL; (1999) Potentiation of the activity of dendritic cells by DNA. In: (pp. p. 93).

Kiani-Alikhan, S; Chester, KA; Ledermann, JA; Beverley, PCL; (1999) Potentiation of the activity of dendritic cells by DNA. BRIT J CANCER , 80 52 - 52.

Koberle, B; Masters, JRW; Hartley, JA; Wood, RD; (1999) Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. CURR BIOL , 9 (5) 273 - 276.

Koh, MBC; Lowdell, MW; Prentice, HG; (1999) The GvH reaction: The 'cytokine storm' and its effect on lymphocyte alloreactive responses. BRIT J HAEMATOL , 105 60 - 60.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (1999) Establishment of the NOD/SCID mouse as a model for allogeneic GvHD. BLOOD , 94 (10) 330B - 330B.

Koh, MBC; Prentice, HG; Corbo, M; Cotter, FE; Morgan, M; Ravell, P; Lowdell, MW; (1999) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in a NOD/SCID mouse model. BLOOD , 94 (10) 330B - 330B.

Koh, MBC; Prentice, HG; Lowdell, MW; (1999) Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis. BONE MARROW TRANSPL , 23 (10) 1071 - 1079.

Kottaridis, PD; Chakraverty, R; Milligan, DW; Chakrabarti, S; Robinson, S; Chopra, R; Pettengell, R; (1999) A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy. BLOOD , 94 (10) 348A - 348A.

Kottaridis, PD; Ketley, N; Peggs, K; Chakraverty, R; Ralleigh, G; Shaw, P; Pezzella, F; (1999) An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion. BONE MARROW TRANSPL , 24 (7) 807 - 809.

Kottaridis, PD; Peggs, K; Harrison, C; Angus, G; Peniket, A; Miller, B; Devereux, S; (1999) Age over 60 is not a barrier for successful autologous stem cell transplantation in selected patients with lymphoma: A single institution's experience in 37 consecutive patients. In: BLOOD. (pp. 170A - 170A). AMER SOC HEMATOLOGY

Kottaridis, PD; Rees, H; Smith, G; Garner, SF; Perry, AR; Peniket, AJ; Goldstone, AH; (1999) A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantation. BONE MARROW TRANSPL , 23 (7) 739 - 741.

L

Lader, CS; Scopes, J; Horton, MA; Flanagan, AM; (1999) Human osteoclasts generated with soluble trance - Differences from stromal-cell based culture systems. JOURNAL OF BONE AND MINERAL RESEARCH , 14 (6) p. 1033.

Lam, EWF; Glassford, J; van der Sman, J; Banerji, L; Pizzey, AR; Thomas, NSB; Klaus, GGB; (1999) Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors. EUR J IMMUNOL , 29 (10) 3380 - 3389.

Langabeer, SE; Gale, RE; Mackinnon, S; Linch, DC; (1999) Transcription mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. BLOOD , 94 (10) 283A - 283A.

Langabeer, SE; Grimwade, D; Walker, H; Burnett, AK; Goldstone, AH; Linch, DC; (1999) EV1-1 expression in acute promyelocytic leukaemia. BRIT J HAEMATOL , 105 74 - 74.

Laplace-Marieze, V; Presneau, N; Sylvain, V; Kwiatkowski, F; Lortholary, A; Hardouin, A; Bignon, YJ; (1999) Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French high-risk families. INT J ONCOL , 14 (5) 971 - 977.

Lawrie, AS; Mackie, IJ; Purdy, G; Kitchen, S; Howarth, D; Martin, J; Rigsby, P; (1999) A comparative study of commercial fibrinogen reference preparations, Clauss and PT-derived fibrinogen assay reagents. THROMB HAEMOSTASIS 605 - 605.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (1999) The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. THROMB HAEMOSTASIS , 81 (5) 758 - 762.

Ledermann, JA; Herd, R; Maraninchi, D; Viens, P; Buclon, M; Chauvin, F; Ferrante, P; (1999) UNSPECIFIED In: (Proceedings) High Dose Chemotherapy in Ovarian Cancer:An Analysis of the Experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 Years. (pp. 360a-).

Ledermann, JA; Maughan, TS; James, RD; Kerr, D; McArdle, C; Seymour, M; Johnston, C; (1999) Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer. British Journal of Cancer , 80 p. 410.

Ledermann, JA; Maughan, TS; James, RD; Kerr, D; McArdle, C; Seymour, M; Johnston, C; (1999) Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer. BRIT J CANCER , 80 20 - 20.

Lee, CK; de Miranda, MP; Ledermann, JA; de Elvira, MCR; Nelstrop, AE; Lambert, HE; Rustin, GJS; (1999) Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy. EUR J CANCER , 35 (5) 727 - 732.

Lee, SM; Radford, JA; Ryder, WD; Deakin, DP; Morgenstern, OR; Scarffe, JH; Crowther, D; (1999) Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma. Bone Marrow Transplantation , 24 (3) pp. 271-277.

Leevers, SJ; Vanhaesebroeck, B; Waterfield, MD; (1999) Signalling through phosphoinositide 3-kinases: the lipids take centre stage. CURRENT OPINION IN CELL BIOLOGY , 11 (2) pp. 219-225. 10.1016/S0955-0674(99)80029-5.

Linch, DC; Goldstone, AH; (1999) High-dose therapy for Hodgkin's disease. BRIT J HAEMATOL , 107 (4) 685 - 690.

Lindh, M; Hannoun, C; Dhillon, AP; Norkrans, G; Horal, P; (1999) Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J INFECT DIS , 179 (4) 775 - 782.

Lindh, M; Savage, K; Rees, J; Garwood, L; Horal, P; Norkrans, G; Dhillon, AP; (1999) HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. LIVER , 19 (4) 294 - 298.

Lowdell, MW; Craston, R; Prentice, HG; (1999) Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following alpha interferon treatment. BRIT J HAEMATOL , 105 78 - 78.

Lowdell, MW; Craston, R; Prentice, HG; (1999) Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following interferon-alpha treatment. CYTOKINES CELL MOL T , 5 (2) 119 - 121.

Lowdell, MW; Wood, ME; Corbo, M; Hennessy, B; Cotter, FE; Craston, R; Prentice, HG; (1999) AML-reactive autologous NK cells predict patient survival and can prevent leukaemia outgrowth in an animal model. BLOOD , 94 (10) 596A - 596A.

Lowdell, MW; Wood, ME; Craston, R; Prentice, HG; (1999) Measurement of autologous immunity to leukaemia can predict maintenance of complete remission at two years. BRIT J HAEMATOL , 105 59 - 59.

M

Macdonald, F; Verma, L; Dhanjal, S; Leedham, P; Szczepura, A; Hulten, M; (1999) A rapid and simple prenatal diagnosis DNA diagnosis of Down syndrome and other common trisomies. CYTOGENET CELL GENET , 85 (1-2) 11 - 11.

Mackinnon, S; Kottaridis, P; Perry, A; Chakrabarti, S; Milligan, DW; Pettengell, R; Chopra, R; (1999) Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation. BRIT J HAEMATOL , 105 31 - 31.

Maini, MK; Casorati, G; Dellabona, P; Wack, A; Beverley, PCL; (1999) T-cell clonality in immune responses. IMMUNOL TODAY , 20 (6) 262 - 266.

Maini, MK; Soares, MVD; Zilch, CF; Akbar, AN; Beverley, PCL; (1999) Virus-induced CD8(+) T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: A mechanism for rescue from replicative senescence. J IMMUNOL , 162 (8) 4521 - 4526.

Majewski, M; Nieborowska-Skorska, M; Salomoni, P; Slupianek, A; Reiss, K; Trotta, R; Calabretta, B; (1999) Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. CANCER RES , 59 (12) 2815 - 2819.

Majumdar, A; Eardley, K; Howie, AJ; Savage, COS; Wheeler, DC; Richards, NT; Adu, D; (1999) Prevalence, predictors and prognostic significance of non-diabetic renal disease (NDRD) in patients with type II diabetes mellitus (NIDM). KIDNEY INT , 55 (6) 2592 - 2592.

Makris, A; Powles, TJ; Allred, DC; Ashley, SE; Trott, PA; Ormerod, MG; Titley, JC; (1999) Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study. Breast Cancer Research And Treatment , 53 pp. 51-59.

Makris, A; Powles, TJ; Kakolyris, S; Dowsett, M; Ashley, SE; Harris, AL; (1999) Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma. Cancer , 85 pp. 1996-2000.

Mangham, DC; Isaacson, PG; (1999) A novel immunohistochemical detection system using mirror image complementary antibodies (MICA). Histopathology , 35 (2) pp. 129-133.

Mann, DJ; Child, ES; Swanton, C; Laman, H; Jones, N; (1999) Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J , 18 (3) pp. 654-663. 10.1093/emboj/18.3.654.

Mao, X; Barfoot, R; Hamoudi, RA; Easton, DF; Flanagan, AM; Stratton, MR; (1999) Allelotype of uterine leiomyomas. Cancer Genet Cytogenet , 114 (2) pp. 89-95.

Marafioti, T; Hummel, M; Anagnostopoulos, I; Foss, HD; Huhn, D; Stein, H; (1999) Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol , 17 (12) pp. 3804-3809. 10.1200/JCO.1999.17.12.3804.

Marsh, SG; (1999) Nomenclature for Factors of the HLA System, update September 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (1) pp. 88-89.

Marsh, SG; (1999) Nomenclature for Factors of the HLA system, update August 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (1) 87-.

Marsh, SG; (1999) Nomenclature for factors of the HLA System, update December 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (3) 271-.

Marsh, SG; (1999) Nomenclature for factors of the HLA System, update November 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (3) pp. 269-270.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update April 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (2) pp. 209-211.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update April 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 60 (9) pp. 918-919.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update February 1999. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (1) pp. 108-109.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update February 1999. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (5) 451-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update January 1999. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (1) pp. 106-107.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update January 1999. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (5) 450-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update July/August 1999. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (11) 1156-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update July/August 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (5) pp. 531-532.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update June 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (3) pp. 322-324.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update June 1999. WHO Nomenclature Committee for Factors of the HLA system. Hum Immunol , 60 (10) pp. 1011-1012.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update March 1999. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (1) pp. 110-111.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update March 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 60 (7) 627-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update May 1999. WHO Nomenclature Committee for Factors of the HLA System. Tissue Antigens , 54 (2) 212-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update May 1999. WHO Nomenclature Committee for factors of the HLA system. Hum Immunol , 60 (9) 920-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update October 1998. WHO Nomenclature Committee for Factors of the HLA System. Hum Immunol , 60 (3) 268-.

Marsh, SG; (1999) Nomenclature for factors of the HLA system, update September 1999. WHO nomenclature committee for factors of the HLA system. Hum Immunol , 60 (12) 1310-.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update April 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (5) pp. 379-380. 10.1046/j.1365-2370.1999.00179.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update December 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (2-3) p. 247.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update February 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (4) p. 317. 10.1046/j.1365-2370.1999.00171.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update January 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (4) p. 315. 10.1046/j.1365-2370.1999.00170.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update July/August 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (6) p. 427. 10.1046/j.1365-2370.1999.00195.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update June 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (5) pp. 383-384. 10.1046/j.1365-2370.1999.00181.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update March 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (4) p. 319. 10.1046/j.1365-2370.1999.00172.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update May 1999. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (5) p. 381. 10.1046/j.1365-2370.1999.00180.x.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update November 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (2-3) pp. 245-246.

Marsh, SGE; (1999) Nomenclature for factors of the HLA system, update October 1998. EUROPEAN JOURNAL OF IMMUNOGENETICS , 26 (2-3) p. 243.

Mathews, F; Murphy, M; Wald, N; Hackshaw, A; (1999) Twinning and folic acid use. The Lancet , 353 291-.

Maxwell, P; Patterson, AH; Jamison, J; Miller, K; Rhodes, CA; Anderson, N; (1999) Alcohol-fixed cytospins protected by 10% polyethylene glycol for immunocytology external quality assurance. J PATHOL , 187 31A - 31A.

Mayer, A; Chester, KA; Flynn, AA; Begent, RH; (1999) Taking engineered anti-CEA antibodies to the clinic. J Immunol Methods , 231 (1-2) pp. 261-273.

Mayer, A; Chester, KA; Flynn, AA; Begent, RHJ; (1999) Taking engineered anti-CEA antibodies to the clinic. J IMMUNOL METHODS , 231 (1-2) 261 - 273.

Mayer, A; Neale, MH; Cree, IA; Hall, P; Grant, J; de Takats, PG; (1999) Feasibility and clinical application of an ATP based tumour chemosensitivity assay (ATP-TCA) in patients with metastatic melanoma. BRIT J CANCER , 80 65 - 65.

McDermott, A; Cohen, SBA; Zuckerman, JN; Madrigal, JA; (1999) Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine , 17 pp. 330-339.

McDermott, AB; Madrigal, JA; Sabin, CA; Zuckerman, JN; Cohen, SB; (1999) The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination. Vaccine , 17 (11-12) pp. 1329-1337.

McHugh, PJ; Gill, RD; Waters, R; Hartley, JA; (1999) Excision repair of nitrogen mustard-DNA adducts in Saccharomyces cerevisiae. NUCLEIC ACIDS RES , 27 (16) 3259 - 3266. Gold open access

McHugh, PJ; Hartley, JA; (1999) The induction and repair of DNA doublestrand breaks in nitrogen mustard treated Saccharomyces cerevisiae cells. BRIT J CANCER , 80 42 - 42.

McLean, M; Bisits, A; Davis, J; Walters, W; Hackshaw, A; de, VK; Smith, R; (1999) Predicting risk of preterm delivery by second trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein. American Journal of Obstetrics and Gynecology , 181 (1) pp. 207-215.

Mchugh, PJ; Hartley, JA; (1999) The induction and repair of DNA doublestrand breaks in nitrogen mustard treated Saccharomyces cerevisiae cells. British Journal of Cancer , 80 p. 54.

Mendoza-Rincon, J; Arguello, JR; Perez-Rodriguez, M; McWhinnie, A; Marsh, SGE; Fischer, G; Madrigal, JA; (1999) Characterization of the MICA polymorphism by sequence-specific oligonucleotide probing. IMMUNOGENETICS , 49 (6) pp. 471-478. 10.1007/s002510050523.

Mengubas, K; Fahey, AA; Lewin, J; Mehta, AB; Hoffbrand, AV; Wickremasinghe, RG; (1999) Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation. EXP CELL RES , 249 (1) 116 - 122.

Mengubas, K; Riordan, FA; Bravery, CA; Lewin, J; Owens, DL; Mehta, AB; Hoffbrand, AV; (1999) Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism. ONCOGENE , 18 (15) 2499 - 2506.

Morgan, NV; Tipping, AJ; Joenje, H; Mathew, CG; (1999) High frequency of large intragenic deletions in the Fanconi anemia group A gene. AM J HUM GENET , 65 (5) 1330 - 1341.

Morris, A; Boyd, E; Dhanjal, S; Lowther, GW; Aitken, DA; Young, J; Menzies, AL; (1999) Two years' prospective experience using fluorescence in situ hybridization on uncultured amniotic fluid cells for rapid prenatal diagnosis of common chromosomal aneuploidies. PRENATAL DIAG , 19 (6) 546 - 551.

Mundee, Y; Bigelow, NC; Davis, BH; Porter, JB; (1999) Effect of adhesion molecule expression on survival of F-cells and F-reticulocytes in sickle cell disorders. BRIT J HAEMATOL , 105 72 - 72.

Mundee, Y; Porter, JB; (1999) Contribution of adhesion molecule expression and F(+)cell production to red cell survival in sickle cell disorders with and without hydroxyurea therapy. BLOOD , 94 (10) 421A - 421A.

N

Nacheva, EP; Sinclair, PB; Laversha, M; Telford, N; Chang, J; Ried, A; Bench, A; (1999) Large deletions at the t(9;22) breakpoint are common and may identify a poor prognostic sub group of patients with chronic myeloid leukemia. BLOOD , 94 (10) 534A - 534A.

Nacheva, EP; Swanton, S; Hood, T; Grace, CD; Bench, A; Green, AR; (1999) Abnormalities of the long arm of chromosome 20 in myeloid malignancies. CYTOGENET CELL GENET , 85 (1-2) 15 - 15.

Nagral, A; Mehta, AB; Gomes, AT; Ellis, G; Jackson, BF; Sabin, CA; McIntyre, N; (1999) Serum soluble transferrin receptor in the diagnosis of iron deficiency in chronic liver disease. Clin Lab Haematol , 21 (2) pp. 93-97.

Napier, MP; Hoare, D; Whelan, JS; (1999) Safe administration of high dose methotrexate in osteosarcoma: Carboxypeptidase G2 for idiosynchratic toxicity. British Journal of Cancer , 80 p. 155.

Napier, NP; Hoare, D; Whelan, JS; (1999) Safe administration of high dose methotrexate in osteosarcoma: carboxypeptidase G2 for idiosyncratic toxicity. In:

Nathwani, AC; Persons, DA; Stevenson, SC; Frare, P; McClelland, A; Nienhuis, AW; Vanin, EF; (1999) Adenovirus-mediated expresssion of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector. Gene Ther , 6 (8) pp. 1456-1468. 10.1038/sj.gt.3300974.

Neidle, S; Mann, J; Rayner, EL; Baron, A; Opoku-Boahen, Y; Simpson, IJ; Smith, NJ; (1999) Symmetric bis-benzimidazoles: new sequence-selective DNA-binding molecules. CHEM COMMUN (10) 929 - 930.

Newby, JC; Leonard, P; Fenwick, E; Harland, SJ; (1999) A phase II study of epirubicin, carboplatin and infusional 5-FU in hormone resistant prostate cancer. British Journal of Cancer , 80 p. 158.

Newell, DR; Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Dewsbury, P; Endicott, JA; (1999) Antiproliferative cyclin dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. Clinical Cancer Research , 5 124-.

Newell, DR; Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Dewsbury, P; Endicott, JA; (1999) Antiproliferative cyclin dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. CLIN CANCER RES , 5 3755S - 3755S.

Ng, T; (1999) Imaging Protein Kinase C Activation in Cells. Science , 283 (5410) pp. 2085-2089. 10.1126/science.283.5410.2085.

Ng, T; Shima, D; Squire, A; Bastiaens, PIH; Gschmeissner, S; Humphries, MJ; Parker, PJ; (1999) PKC alpha regulates beta 1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J , 18 (14) 3909 - 3923.

Ng, TTC; Collins, IE; Kanner, SB; Humphries, MJ; Amft, N; Wickremasinghe, RG; D'Cruz, D; (1999) Integrin signalling defects in T-lymphocytes in systemic lupus erythematosus. LUPUS , 8 (1) 39 - 51.

Nieborowska-Skorska, M; Wasik, MA; Slupianek, A; Salomoni, P; Kitamura, T; Calabretta, B; Skorski, T; (1999) Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J EXP MED , 189 (8) 1229 - 1242.

Nitu, IC; Lee, CA; Dhillon, AP; Mistry, PK; (1999) Management of liver failure in a haemophilic patient co-infected with human immunodeficiency and hepatitis C viruses. CLIN LAB HAEMATOL , 21 (2) 139 - 141.

Noble, KE; Wickremasinghe, RG; DeCornet, C; Panayiotidis, P; Yong, KL; (1999) Monocytes stimulate expression of the Bcl-2 family mamber ,A1, in endothelia cells and confer protection against apoptosis. The Journal of Immunology , 162 (3) pp. 1376-1383.

Noble, KE; Wickremasinghe, RG; DeCornet, C; Panayiotidis, P; Yong, KL; (1999) Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J IMMUNOL , 162 (3) 1376 - 1383.

Novelli, MR; Wasan, H; Rosewell, I; Bee, J; Tomlinson, IP; Wright, NA; Bodmer, WF; (1999) Tumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimeras. Proc Natl Acad Sci U S A , 96 (22) pp. 12553-12558.

Novelli, MR; Wasan, H; Tomlinson, IPM; Rosewell, I; Bee, J; Wright, NA; Bodmer, WF; (1999) Polyp number and clonality in Min mouse aggregation chimaeras. Proceedings of the National Academy of Sciences of the United States of America , 96 (22) pp. 12553-12558.

Nutting, C; Brada, M; Brazil, L; Sibtain, A; Saran, F; Westbury, C; Moore, A; (1999) Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg , 90 (5) pp. 823-827. 10.3171/jns.1999.90.5.0823.

O

O'Neil, D; Swanton, C; Jones, A; Medd, PG; Rayment, N; Chain, B; (1999) IFN-gamma down-regulates MHC expression and antigen processing in a human B cell line. JOURNAL OF IMMUNOLOGY , 162 (2) pp. 791-798.

Orchard, KH; Cooper, M; Mehta, A; Potter, M; Wijdenes, J; Borchardt, P; Quadri, S; (1999) Targeted radiotherapy for patients with multiple myeloma: Results of pre-clinical evaluation of candidate antibodies. BLOOD , 94 (10) 302B - 302B.

Orchard, KH; Cooper, M; Mehta, A; Potter, M; Wijdenes, J; Borchardt, P; Quadri, S; (1999) Targeted radiotherapy for patients with multiple myeloma: Results of pre-clinical evaluation of candidate antibodies. Blood , 94 p. 4576.

Osborne, M; GlynneJones, R; Galbraith, S; Burcombe, R; Makris, A; (1999) Squamous cell carcinoma antigen as a marker of epidermoid carcinoma of the anal canal. British Journal of Cancer , 80 p. 117.

Osborne, M; GlynneJones, R; Hoskin, P; Saunders, M; Makris, A; (1999) Continuous hyperfractionated accelerated radiotherapy +/-concurrent infusional 5FU in advanced rectal cancer. British Journal of Cancer , 80 p. 114.

Osbourn, JK; McCafferty, J; Derbyshire, EJ; Waibel, R; Chester, K; Boxer, G; Allen, D; (1999) Isolation of a panel of human anti-CEA single chain Fv from a large phage display library. Tumor Targeting , 4 pp. 150-157.

Osman, M; Kubo, T; Gill, J; Neipel, F; Becker, M; Smith, G; Weiss, R; (1999) Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J VIROL , 73 (7) 6136 - 6140.

P

Page, MJ; Amess, B; Townsend, RR; Parekh, R; Herath, A; Brusten, L; Zvelebil, MJ; (1999) Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 96 (22) pp. 12589-12594. 10.1073/pnas.96.22.12589.

Pang, KF; Ganeshaguru, K; Hart, SM; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; (1999) Expression of the multidrug resistance protein gene homologues in B-CLL and AML cells. BLOOD , 94 (10) 280A - 280A.

Paniwnyk, Z; Pors, K; TeesdaleSpittle, PH; Potter, GA; Plumb, J; Hartley, JA; Patterson, LH; (1999) Novel inhibitor of topo II is effective against resistant ovarian cancer cells. British Journal of Cancer , 80 p. 69.

Papatheodoridis, GV; Barton, SGRG; Andrew, D; Clewley, G; Davies, S; Dhillon, AP; Dusheiko, G; (1999) Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens. GUT , 45 (3) 427 - 434.

Paramio, JM; Casanova, ML; Segrelles, C; Mittnacht, S; Lane, EB; Jorcano, JL; (1999) Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol , 19 (4) pp. 3086-3094.

Parkinsoin, MC; Harland, SJ; (1999) Testis cancer. In: Mundy, AR and Fitzpatrick, JM and Neal, DE and George, NJR, (eds.) Scientific Basis of Urology. (pp. 375-394). Isis Medical Media Ltd: Oxford, UK.

Pawson, R; Rajan, S; Hazlehurst, G; Dusheiko, G; Miller, R; Hewitt, P; Mehta, A; (1999) Hepatitis C lookback programme: a single hospital experience. Transfusion Medicine , 9 (3) pp. 189-193.

Pearce, D; Pizzey, A; Uhr, M; Gordon-Smith, EC; Pettengell, RCP; McGuckin, CP; (1999) Intracellular CD34 progenitor subset analysis. BRITISH JOURNAL OF HAEMATOLOGY , 105 p. 57.

Pedley, RB; Sharma, SK; Boxer, GM; Boden, R; Stribbling, SM; Davies, L; Springer, CJ; (1999) Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent. Cancer Res , 59 (16) pp. 3998-4003.

Pedley, RB; Sharma, SK; Boxer, GM; Boden, R; Stribbling, SM; Davies, L; Springer, CJ; (1999) Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent. CANCER RES , 59 (16) 3998 - 4003.

Peggs, KS; Kottaridis, PD; Preiser, W; McCaig, N; Brink, N; Ward, K; Tedder, R; (1999) Molecular monitoring for CMV infection after allogeneic transplantation: Benefits and limitations of PCR directed pre-emptive antiviral therapy. In: BLOOD. (pp. 337A - 337A). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Ainsworth, J; Pizzey, A; Moss, PAH; Mackinnon, S; (1999) CMV specific HLA-tetramer sorting of ex-vivo expanded CD8+CTL: Selection of highly restricted clonal populations suitable for adoptive cellular therapy. In: BLOOD. (pp. 395A - 395A). AMER SOC HEMATOLOGY

Pellett, PE; Spira, TJ; Bagasra, O; Boshoff, C; Corey, L; de Lellis, L; Huang, ML; (1999) Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J CLIN MICROBIOL , 37 (5) 1298 - 1301.

Peng, HZ; Du, MQ; Koulis, A; Aiello, A; Dogan, A; Pan, LX; Isaacson, PG; (1999) Nonimmunoglobulin gene hypermutation in germinal center B cells. BLOOD , 93 (7) pp. 2167-2172.

Perez-Rodriguez, M; Arguello, R; Fischer, G; Cox, S; McWhinnie, A; Corell, A; Travers, PJ; (1999) Does the polymorphism of MICA influence bone marrow transplant complications? BLOOD , 94 (10) 393B-393B.

Perry, AR; Peniket, AJ; Watts, MJ; Leverett, D; Goldstone, AH; Linch, DC; (1999) Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis. BRIT J HAEMATOL , 105 (1) 280 - 287.

Peruzzi, F; Prisco, M; Dews, M; Salomoni, P; Grassilli, E; Romano, G; Calabretta, B; (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. MOL CELL BIOL , 19 (10) 7203 - 7215.

Platt, GM; Simpson, GR; Mittnacht, S; Schulz, TF; (1999) Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol , 73 (12) pp. 9789-9795.

Plummer, R; Rees, C; Judson, I; Calvert, H; Highley, M; Trigo, J; Jackman, A; (1999) Phase I trial of ZD9331 in adult patients with refractory solid malignancies administered by 30-min infusion on days 1 and 8 with the cycle repeated every 3 weeks. EUR J CANCER , 35 S285 - S285.

Pollard, Y; Watts, MJ; Grant, D; Chavda, N; Linch, DC; Machin, SJ; (1999) Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. BRIT J HAEMATOL , 106 (2) 538 - 544.

Porakishvili, N; Roshupkina, T; Jewell, AP; Patterson, K; Yong, K; Lydyard, PM; (1999) Circulating CD4+ cells in patients with B-chronic lymphocytic leukaemia (B-CLL) express perforin (PF) and serine esterase (SE). Immunology , 98 (Suppl) 20-.

Powell, MEB; Collingridge, DR; Saunders, MI; Hoskin, PJ; Hill, SA; Chaplin, DJ; (1999) Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. Radiotherapy and Oncology , 50 pp. 167-171.

Presneau, N; Laplace-Marieze, V; Sylvain, V; Lortholary, A; Hardouin, A; Bernard-Gallon, D; Bignon, YJ; (1999) Mutation by deletion-insertion in BRCA-1 gene in three unrelated French breast ovarian cancer families: possible implication of a mobile element. B CANCER , 86 (4) 385 - 390.

R

Rees, DC; Porter, JB; Clegg, JB; Weatherall, DJ; (1999) Why are hemoglobin F levels increased in HbE/beta thalassemia? BLOOD , 94 (9) 3199 - 3204.

Rege, KP; Bevan, DH; Chitolie, A; Shannon, MS; (1999) Risk factors and thrombosis after airline flight. THROMB HAEMOSTASIS , 81 (6) 995 - 996.

Roberts, I; Wienberg, J; Nacheva, E; Grace, C; Griffin, D; Coleman, N; (1999) Novel method for the production of multiple colour chromosome paints for use in karyotyping by fluorescence in situ hybridisation. Genes Chromosomes Cancer , 25 (3) pp. 241-250.

Roberts, PJ; Mollapour, E; Watts, MJ; Linch, DC; (1999) Primitive myeloid cells express high levels of phospholipase A(2) activity in the absence of leukotriene release: Selective regulation by stem cell factor involving the MAP kinase pathway. BLOOD , 94 (4) 1261 - 1272.

Robertson, J; Gale, RE; Linch, DC; Testa, NG; Chopra, R; (1999) Acquired skewed haemopoiesis in the elderly is independent of telomere shortening-implications for stem cell utilisation. BLOOD , 94 (10) 254A - 254A.

Robertson, JD; Gale, R; Wynn, RF; Robinson, SA; Greaves, MJ; Dougal, M; Linch, DC; (1999) Telomere shortening in peripheral blood neutrophils and T cells with age in healthy individuals. BRIT J HAEMATOL , 105 103 - 103.

Robinson, M; Machin, S; Mackie, I; Harrison, P; (1999) In vivo biotinylation studies: Specificity of labelling of reticulated platelets by thiazole orange and mepacrine. THROMB HAEMOSTASIS 826 - 826.

S

Sathar, MA; Soni, PN; Pegoraro, R; Simmonds, P; Smith, DB; Dhillon, AP; Dusheiko, GM; (1999) A new variant of GB virus C/hepatitis G virus (GBV-C/HGV) from South Africa. VIRUS RES , 64 (2) 151 - 160.

Saunders, M; Dische, S; Barrett, A; Harvey, A; Griffiths, G; Parmar, M; (1999) Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. Radiotherapy and Oncology , 52 (2) pp. 137-148. 10.1016/S0167-8140(99)00087-0.

Saunders, MI; Dische, S; Rojas, A; (1999) CHART (continuous, hyperfractionated, accelerated radiotherapy): a tale of two disciplines. Br J Cancer , 80 Sup pp. 110-115. 10.1038/sj.bjc.6690329.

Savage, K; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Bret, BT; Pounder, RE; (1999) Trafficking of CCK-B/gastrin receptor in tumour cells using confocal microscopy. GUT , 44 A85 - A85.

Savage, K; Khan, K; Dhillon, AP; Grimes, S; Michaeli, D; Brett, BT; Pounder, RE; (1999) Trafficking of CCK-B/gastrin receptor in tumour cells using confocal microscopy. GASTROENTEROLOGY , 116 (4) A642 - A642.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Noreen, H; Setterholm, M; (1999) The HLA dictionary 1999: a summary of HLA-A, -B, -C, –DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens , 54 (4) pp. 409-437. 10.1034/j.1399-0039.1999.540412.x.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Noreen, H; Setterholm, M; (1999) HLA dictionary 1999: a summary of HLA-A, -B, -Cw, –DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Human Immunology , 60 pp. 1157-1181.

Shamash, J; Lee, SM; Deakin, DP; Scarffe, JH; Morgenstern, GR; Chang, J; Gupta, RK; (1999) High dose chemotherapy (HDCT) with autologous haematopoietic support in recurrent or refractory Hodgkin’s lymphoma (HL). In: (Proceedings) British Cancer Research Meeting, Edinburgh.. (pp. 18-). British Journal of Cancer

Shankar, A; Renaut, AJ; Ledermann, J; Lees, W; Gillams, A; Harrison, E; Taylor, I; (1999) Neoadjuvant therapy improves resectability rates for colorectal liver metastases. BRIT J CANCER , 80 56 - 56.

Shanker, A; Renaut, AJ; Whelan, JS; Taylor, I; (1999) Colorectal cancer in adolescents. Annals of the Royal College of Surgeons of England , 81 (2) pp. 100-104.

Shaw, BE; Potter, MN; Pawson, R; Virchis, AE; Patch, D; Murphy, K; Perry, D; (1999) The use of defibrotide in the management of vascular endothelial complications (VOD/HUS/TTP) of stem cell transplantation. BLOOD , 94 (10) 608A - 608A.

Shoab, SS; Porter, J; Scurr, JH; Coleridge-Smith, PD; (1999) Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease - a prospective study. EUR J VASC ENDOVASC , 17 (4) 313 - 318.

Short, S; (1999) UNSPECIFIED In: (Proceedings) The Royal College of Radiologists Annual Scientific Meeting.

Short, S; (1999) The response of human glioma cells to low dose radiation. International journal of radiation biology , 75 pp. 1341-1348.

Short, S; Mayes, C; Woodcock, M; Joiner, MC; (1999) Low-dose hypersensitivity in the T98G glioblastoma cell line. International journal of radiation biology , 75 pp. 847-855.

Sirivatanauksorn, Y; Sirivatanauksorn, V; Bhattacharya, S; Davidson, BR; Dhillon, AP; Kakkar, AK; Williamson, RCN; (1999) Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting. J PATHOL , 189 (3) 344 - 350.

Sirivatanauksorn, Y; Sirivatanauksorn, V; Bhattacharya, S; Davidson, BR; Dhillon, AP; Kakkar, AK; Williamson, RCN; (1999) Genomic heterogeneity in synchronous hepatocellular carcinomas. GUT , 45 (5) 761 - 765.

Sirotnak, FM; Tolner, B; (1999) Carrier-mediated membrane transport of folates in mammalian cells. ANNU REV NUTR , 19 91 - 122.

Sitas, F; Carrara, H; Beral, V; Newton, R; Reeves, G; Bull, D; Jentsch, U; (1999) Antibodies against human herpesvirus 8 in black South African patients with cancer. NEW ENGL J MED , 340 (24) 1863 - 1871.

Sitas, F; Newton, R; Boshoff, C; (1999) Increasing probability of mother-to-child transmission of HHV-8 with increasing maternal antibody titer for HHV-8. NEW ENGL J MED , 340 (24) 1923 - 1923.

Small, TN; Papadopoulos, EB; Boulad, F; Black, P; Castro-Malaspina, H; Childs, BH; Collins, N; (1999) Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood , 93 (2) pp. 467-480.

Smith, NA; Sabin, CA; Gopal, R; Bourboulia, D; Labbet, W; Boshoff, C; Barlow, D; (1999) Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. JOURNAL OF INFECTIOUS DISEASES , 180 (3) 600 - 606.

Smith, PG; Barlow, HC; Loughlin, P; Huang, B; Bowman, KJ; Calvert, AH; Curtin, NJ; (1999) Novel dipyridamole analogues potentiate the in vitro activity of MTA (LY231514) in the presence of alpha(1)-acid glycoprotein. British Journal of Cancer , 80 82-.

Smith, PG; Bewley, J; Gogel, JA; Calvert, AH; Newell, DR; Curtin, NJ; Chen, VJ; (1999) MTA (LY231514) induced intracellular dNTP pool pertubations are alleviated by salvage of pre-formed purines and pyrimidines. British Journal of Cancer , 80 83-.

Smith, PG; Marshman, E; Calvert, AH; Newell, DR; Curtin, NJ; (1999) Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines. SEMINARS IN ONCOLOGY , 26 (2) 63 - 67.

Somervaille, TCP; Kirk, S; Dogan, A; Landon, GV; Mackinnon, S; (1999) Fulminant hepatic failure caused by adenovirus infection following bone marrow transplantation for Hodgkin's disease. BONE MARROW TRANSPL , 24 (1) 99 - 101.

Spanswick, VJ; Hartley, JM; Ward, TH; Hartley, JA; (1999) Measurement of drug-induced DNA interstrand crosslinking using the single-cell gel electrophoresis (comet) assay. Methods Mol Med , 28 pp. 143-154. 10.1385/1-59259-687-8:143.

Speidel, K; Samady, L; Ledermann, JA; Chain, BM; Coffin, R; Katz, D; (1999) Development of transfected dendritic cells for immunotherapy of ovarian cancer. BRIT J CANCER , 80 21 - 21.

Spencer, DIR; Robson, L; Bhatia, J; Sharma, SK; Michael, NP; Whitelegg, NR; Rees, AR; (1999) Identifying immunogenic sites on adept enzymes CPG2 using a SCFV phage library & SELDI (TM)-AMS. In: (pp. p. 94).

Spencer, DIR; Robson, L; Bhatia, J; Sharma, SK; Michael, NP; Whitelegg, NR; Rees, AR; (1999) Identifying immunogenic sites on adept enzymes CPG2 using a SCFV phage library & SELDI (TM)-AMS. BRIT J CANCER , 80 52 - 52.

Srichairatanakool, S; Davis, BA; Porter, JB; (1999) Direct chelation of NTBI by desferrioxamine does not occur at clinically relevant rates in plasma. BRIT J HAEMATOL , 105 72 - 72.

Stein, H; Diehl, V; Marafioti, T; Jox, A; Wolf, J; Hummel, M; (1999) The nature of Reed-Sternberg cells, lymphocytic and histiocytic cells and their molecular biology in Hodgkin’s disease. In: Mauch, P, (ed.) Hodgkin’s Disease. Lippincott Williams &Wilkins-Philadelphia

Stein, K; Hummel, M; Korbjuhn, P; Foss, HD; Anagnostopoulos, I; Marafioti, T; Stein, H; (1999) Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. Blood , 94 (8) pp. 2800-2808.

Steingruber, HE; Dunham, A; Coffey, AJ; Clegg, SM; Howell, GR; Maslen, GL; Scott, CE; (1999) High-resolution landmark framework for the sequence-ready mapping of Xq23-q26.1. GENOME RES , 9 (8) 751 - 762.

Stephens, R; Horton, R; Humphray, S; Rowen, L; Trowsdale, J; Beck, S; (1999) Gene organisation, sequence variation and isochore structure at the centromeric boundary of the human MHC. J MOL BIOL , 291 (4) 789 - 799.

Stephenson, JM; Griffioen, A; Woronowski, H; Phillips, AN; Petruckevitch, A; Keenlyside, R; Johnson, AM; (1999) Survival and progression of HIV disease in women attending GUM/HIV clinics in Britain and Ireland. SEX TRANSM INFECT , 75 (4) 247 - 252.

Stoeber, K; Halsall, I; Freeman, A; Swinn, R; Doble, A; Morris, L; Coleman, N; (1999) Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. LANCET , 354 (9189) 1524 - 1525.

Strauss, S; McTiernan, A; Whelan, JS; (1999) Recurrence of osteosarcoma after disease-free intervals exceeding 5 years. In:

Summers, Y; Middleton, MR; Calvert, H; Lee, SM; Rustin, R; Newell, DR; Thatcher, N; (1999) Effect of temozolomide (TMZ) on central nervous system relapse in patients with advanced melanoma. In: (Proceedings) 1999 ASCO Annual Meeting/35th Annual Meeting, Atlanta, GA.. (pp. 531a-). Proceedings of the American Society of Clinical Oncology

Swanton, C; Card, GL; Mann, D; McDonald, N; Jones, N; (1999) Overcoming inhibitions: subversion of CKI function by viral cyclins. Trends Biochem Sci , 24 (3) pp. 116-120.

Sweetenham, JW; Carella, AM; Taghipour, G; Cunningham, D; Marcus, R; Della Volpe, A; Linch, DC; (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation. J CLIN ONCOL , 17 (10) 3101 - 3109.

T

Talbot, SJ; Weiss, RA; Kellam, P; Boshoff, C; (1999) Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. VIROLOGY , 257 (1) 84 - 94.

Tamrakar, S; Mittnacht, S; Ludlow, JW; (1999) Binding of select forms of pRB to protein phosphatase type 1 independent of catalytic activity. Oncogene , 18 (54) pp. 7803-7809. 10.1038/sj.onc.1203211.

Theocharous, P; Lowdell, MW; Jones, AL; Prentice, HG; (1999) Ultrasensitive immunocytochemical and fluorescent detection and characterisation of circulating and micrometastatic tumour cells in patients with breast cancer. BRIT J HAEMATOL , 105 60 - 60.

Thorpe, KL; Schafer, AJ; Genin, E; Trowsdale, J; Beck, S; (1999) Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis. IMMUNOGENETICS , 49 (4) 256 - 265.

Thorpe, KL; Schafer, AJ; Genin, E; Trowsdale, J; Beck, S; (1999) Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis (vol 49, pg 256, 1999). IMMUNOGENETICS , 50 (1-2) 113 - 113.

Tolner, B; Singh, A; Esaki, T; Roy, K; Sirotnak, FM; (1999) Transcription of the mouse RFC-1 gene encoding a folate transporter. Multiplicity and properties of promoters with minimum requirements for their basal activity. GENE , 231 (1-2) 163 - 172.

Tonks, S; Marsh, SG; Bunce, M; Bodmer, JG; (1999) Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop. Tissue Antigens , 53 (2) pp. 175-183.

Tsui, WMS; Colombari, R; Portmann, BC; Bonetti, F; Thung, SN; Ferrell, LD; Nakanuma, Y; (1999) Hepatic angiomyolipoma - A clinicopathologic study of 30 cases and delineation of unusual morphologic variants. AM J SURG PATHOL , 23 (1) 34 - 48.

Tsuzuki, S; Towatari, M; Saito, H; Enver, T; (1999) Potentiation of gata-factor activities through interactions with tee promyelocytic leukemia protein (PML) and the t(15;17) generated PML-RAR alpha oncoprotein. BLOOD , 94 (10) 258A-259A.

U

UK, FCG; (1999) A multicentre study of combination of Fludarabine phospate, cytosine arabinoside and granulocyte-colony stimulator factor (FLAG) in relapsed and refractory acute myeloid leukaemia and de novo RAEB-T. Trends in Onco-Hematology , 7 (2) pp. 27-29.

V

Vanhaesebroeck, B; Higashi, K; Raven, C; Welham, M; Anderson, S; Brennan, P; Ward, SG; (1999) Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. The EMBO Journal , 18 (5) pp. 1292-1302.

Vanhaesebroeck, B; Higashi, K; Raven, C; Welham, M; Anderson, S; Brennan, P; Ward, SG; (1999) Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J , 18 (5) pp. 1292-1302. 10.1093/emboj/18.5.1292.

Vanhaesebroeck, B; Jones, GE; Allen, WE; Zicha, D; Hooshmand-Rad, R; Sawyer, C; Wells, C; (1999) Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. NATURE CELL BIOLOGY , 1 (1) pp. 69-71. 10.1038/9045.

Vanhaesebroeck, B; Waterfield, MD; (1999) Signaling by distinct classes of phosphoinositide 3-kinases. EXPERIMENTAL CELL RESEARCH , 253 (1) pp. 239-254. 10.1006/excr.1999.4701.

Verfuerth, S; Peggs, K; Mackinnon, S; (1999) Generation of CMV-specific T cells for adoptive immunotherapy after allogeneic BMT: A novel in vitro culture assay that is free of live virus which uses donor dendritic cells pulsed with CMV antigen. In: BLOOD. (pp. 155A - 155A). AMER SOC HEMATOLOGY

Verfuerth, S; Peggs, KS; Vyas, P; Barnett, L; O'Reilly, RJ; Mackinnon, S; (1999) Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping following T cell depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T cell repertoire. In: BLOOD. (pp. 344A - 345A). AMER SOC HEMATOLOGY

Vevs, P; Davies, G; Webb, D; Jones, A; Hassan, A; Pagliuca, A; Mufti, GJ; (1999) Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing unrelated related donor BMT. BRIT J HAEMATOL , 105 66 - 66.

Veys, PA; Davies, EG; Webb, D; Jones, A; Hassan, A; Pagliuca, A; Mufti, GJ; (1999) Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing bone marrow transplantation. PEDIATR RES , 45 (5) 768 - 768.

Vig, S; Chitolie, A; Maurice, E; Boa, F; Bevan, DH; Halliday, A; Dormandy, J; (1999) Thromboelastography as a screen for hypercoagulable states predicts failure of peripheral arterial intervention. BLOOD , 94 (10) 114B - 114B.

Vincent-Lacaze, N; Snyder, RO; Gluzman, R; Bohl, D; Lagarde, C; Danos, O; (1999) Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol , 73 (3) pp. 1949-1955.

W

Wald, NJ; Hackshaw, AK; (1999) Development and implementation of Down's syndrome screening. In: Beazoglou, T and Benn, P and Cuckle, H and Haddow, J and Kyriopoulos, J, (eds.) Down syndrome: Screening policy and economic evaluations. (pp. 55-68). National School of Public Health, Exandus Publishers, Athens

Wald, NJ; Hackshaw, AK; Diamandis, EP; Melegos, DN; Int Prenatal Screening Res Grp, ; (1999) Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy. PRENATAL DIAG , 19 (7) 674 - 676.

Wald, NJ; Hackshaw, AK; Frost, CD; (1999) When can a risk factor be used as a worthwhile screening test? BRIT MED J , 319 (7224) 1562 - 1565.

Wald, NJ; Hackshaw, AK; Watt, H; (1999) Nuchal translucency and trisomy 18. PRENATAL DIAG , 19 (10) 995 - 996.

Wald, NJ; Watt, HC; Hackshaw, AK; (1999) Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. NEW ENGL J MED , 341 (7) 461 - 467.

Watts, MJ; Ings, SJ; Chavda, N; Mackinnon, S; Devereux, S; Linch, DC; (1999) Evaluation of clinical scale CD34+cell purification devices. BRIT J HAEMATOL , 105 58 - 58.

Watts, MJ; Ings, SJ; Flynn, M; Dodds, D; MacMillan, A; Goldstone, AH; Linch, DC; (1999) Remobilization of poor stem cell mobilizers is clinically worthwhile. BLOOD , 94 (10) 328A - 328A.

Webley, SD; Francis, R; Begent, RHJ; Hartley, JA; Hochhauser, D; (1999) Measurement of the critical DNA lesions produced by antibody directed enzyme prodrug therapy (ADEPT). BRIT J CANCER , 80 47 - 47.

Wedderburn, LR; Maini, MK; Patel, A; Beverley, PCL; Woo, P; (1999) Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood. INT IMMUNOL , 11 (4) 535 - 543.

Westin, J; Lagging, LM; Wejstal, R; Norkrans, G; Dhillon, AP; (1999) Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. LIVER , 19 (3) 183 - 187.

Wheadon, H; Roberts, PJ; Watts, MJ; Linch, DC; (1999) Changes in signal transduction downstream from the granulocyte-macrophage colony-stimulating factor receptor during differentiation of primary hemopoietic cells. EXP HEMATOL , 27 (6) 1077 - 1086.

Whelan, J; Hoare, D; Leonard, P; (1999) Omeprazole does not alter plasma methotrexate clearance. Cancer Chemother Pharmacol , 44 (1) pp. 88-89. 10.1007/s002800050949.

Whelan, JS; Goodchild, K; Strauss, S; McTiernan, A; Driver, D; Kilby, AM; Cassoni, AM; (1999) Intensive induction therapy (VIDE) including stem cell collection for Ewing's family of tumours. In: